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SWIARY
SUT'IMARY
Although the caliciviruses - San Miguel sealion virus, 
vesicular exanthema virus of swine and feline calicivirus - have been 
considered a provisional genus of the picornaviridae family (Melnick 
ejb ad, 1974), as more information becomes available, especially in the 
area of molecular biology, it becomes increasingly clear that these 
are not true picornaviruses and hence the suggestion by various workers 
that these viruses be regarded as a separate virus family.
The aim of this study, therefore, was to extend our knowledge 
of feline caliciviruses: in particular, to examine the structure of the 
calicivirus particle and the way in which it is assembled. There were 
four main intentions: first, to determine whether the viral capsid 
was constructed from smaller subunits; secondly, to identify such 
subunit structures in FCV-infected cells and examine the roles they 
play in virion assembly; thirdly, to study and compare the antigenic 
properties of the whole virus particle relative to a major virus subunit; 
and fourthly, if both particles showed identical antigenic determinants, 
to exploit the potential of the subunit component as a source of material 
for vaccine production.
Chapter 5 describes the subunit structure of FCV. From virus 
harvests, two homogeneous populations of viral components called peak I 
and peak II were isolated from FCV-infected cell cultures. Peak I banded 
at a density of l*59g*cm"'^ in CSCI2 gradients, had a sedimentation 
coefficient of 17OS, contained RNA, was infectious and showed 
characteristic FCV particles by electron microscopy. This was the 
virus. The other component (peak II) had a buoyant density of l'26g.cm"5, 
had a sedimentation coefficient of I5S , contained no RITA and was non- 
inf ectious. Electron microscopic examination showed that peak II contained 
a large mass of homogeneous materials, the detailed nature of which was 
unclear. However, polypeptide analysis by polyacrylamide gel 
electrophoresis revealed that both peaks I and II contained the major 
FCV capsid protein of 65,000 molecular weight. Also, as described in 
Chapter 5» the virus and the I5S material shared an antigenic 
determinant. These results showed that peak II probably contained virus- 
specified material, possibly viral subunits. A series of experiments 
showed that the I5S component was a stable product of FCV infection and 
was not generated from the virion by the conditions of viral growth 
and purification.
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Subsequent studies showed that FCV is assembled from subunits 
in at least two stages. Purified virus was degraded by low pll in the 
presence of 0'7>I CSCI2 into a non-infectious 158 component which on 
exposure to reducing agents was converted to a 58 subunit. Both 158 and 
5S subunits contained the single major capsid polypeptide of molecular 
weight 65,000 (p65). Similarly, "viral” and "natural” (peak II) I5S 
subunits cosedimented in sucrose gradients, and, as described in 
Chapter 5> are antigenically identical.
In Chapter 4 » experiments are described which show that the FCV 
virion is assembled from these subunits. It was found that FCV infection 
rapidly inhibited cellular protein synthesis and that 120-150 minutes 
after the beginning of infection almost all newly synthesised protein 
was virus-specific. This was demonstrated by polyacrylamide gel 
electrophoresis of cell extracts examined at intervals after infection.
The major polypeptide which appeared was the viral capsid protein, p65. 
Four other newly synthesised polypeptides of molecular weights 80,000 
(2), 40,000 and 14,000 were apparent during the later stages of FCV 
infection. Only the component of 14,000 molecular weight could be shown 
to be related to the virus. The origin and purpose of the other three 
molecules was not determined; they did not appear, however, to be 
precursors or products of the p65.
Pulse-chase experiments showed that the virus was constructed 
from smaller particles. In FCV-infected cells pulsed for 5 seconds with 
^H-leucine at about 200 minutes after infection, newly synthesized virus 
polypeptide (p65) was extremely rapidly converted into a 58 component 
which, possibly through series of unstable intermediates, was incorporated 
within 50 seconds into a I5S subunit. Between I5 and 30 minutes after 
the initiation of protein synthesis, complete feline calicivirions were 
formed in infected cells.
In an analysis of the antigenic determinants of the virus 
(chapter 5), purified, concentrated virus or 15S subunits were inoculated 
into rabbits to produce homologous antisera. These were then analysed by 
virus neutralization and immunodiffusion tests. The results showed that 
both antisera contained neutralizing antibodies to the virus. Analysis 
by immunodiffusion revealed that two antigenic determinants were present 
on the virus particle and one of these was also found on the 158 subunit. 
When the common antibody was absorbed from the antiviral serum with 
excess 158 antigen, the absorbed serum failed to neutralize virus
xii
infectivity indicating that the neutralizing activities of the viral 
and 15s antisera were specific functions of antibody to the common 
antigen.
This result suggested the possible use of the 158 subunit as 
vaccine against calicivirus disease in cats and an experiment to this 
end is described in Chapter 6, A prototype vaccine was prepared by 
purifying the I5S subunit by rate zonal and equilibrium ultra­
centrifugation followed by filtration of the preparation through 
membranes with a pore size of 25nm to exclude any infectious virus.
The purified antigen was inoculated into cats with aluminium hydroxide 
adjuvant. The cats developed FCV neutralizing antibodies and resisted 
challenge with virulent FCV.
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NOTE OIT NOI^ DRTCLA'TURE
Throughout this thesis, the term "p65" is used to describe the 
virion polypeptide. This is because in early experiments its molecular 
weight was estimated to be 65,000 both by polyacrylamide gel 
electrophoresis in a continuous phosphate buffer system and by agarose 
chromatography in guanidine hydrochloride. In later experiments 
involving polyacrylamide gel electrophoresis in a discontinuous tris- 
buffered system an apparent molecular weight of 68,000 was found. For 
convenience the original term is used throughout.
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CHAPTER 1
GENERAL BITRODUCTION
Feline caliciviruses (FCV) are major causes of respiratory 
disease in cats and may be isolated from cases of disease and from 
convalescent carriers (Gillespie & Scot, 1975). The virus can also be 
isolated from 8$^  of normal household cats, 249  ^of cats at shows and 
41*5^ of cats in colonies (Wardley et 1974)*
Other caliciviruses have been isolated from pigs (Madin, 1970) and 
wild pinnipeds ( Smith ^  ad, 1975) and calicivirus-like particles have 
been observed in human infants (Madeley, 1976) and calves (Bridger &
Woods, personal communication).
As discussed below, caliciviruses are small, simple, RNA-containing 
viruses which were provisionally classified as picornaviruses (Melnick 
et al, 1974) although they differ in structure (Zwillenberg & Burki, I966) 
and certain biochemical features from other picornaviruses (Brown & Hull, 
1975; Burroughs & Brown, 1974)* Furthermore, they are unique among the 
picornaviruses in that the capsid consists of only one major polypeptide 
(Bachrach & Hess, 1975; Burroughs & Brown, 1974).
Discovery of feline caliciviruses
Soon after the original isolation of feline rhinotracheitis virus, 
now termed "feline herpesvirus", (Crandell & Maurer, 1958) it became 
apparent that respiratory disease in the cat was also associated with a 
distinctive group of viruses composed of several antigenic types (Crandell 
& Madin, I96O; Bittle at I960; Percy & Prydie, I965). These strains 
were later shown by Burki (1965), Prydie (1966) and Crandell (I967) to 
exhibit the major properties of picornaviruses (Melnick et I965) and 
as such were referred to as "feline picornaviruses".
The first isolation of a feline calicivirus was by Pastier (1957) 
in New Zealand. Subsequently, it has been recovered from cats in many 
parts of the world including Switzerland (Burki, I965),Austria (Zwillenberg 
& Burki, 1966), Italy (Torlone, I96O), England (Prydie, I966; Povey, I969) 
Australia (Studdert ejb ^1, I970); the United States of America (Bolin,
1957; Sinha, 1958; Bittle at ad, I96O; Crandell & Madin, I96O; Kahn & 
Gillespie, 1970) and Scotland (Ormerod and Jarrett, 1978). The virus has 
been isolated from the oropharyngeal region of both infected (Crandell & 
York, 1966) and clinically healthy cats (Walton & Gillespie, 1970; Povey 
& Johnson, 1971) and also from the spleen, kidney and other organs 
(Pastier, 1957). Feline caliciviruses exert a rapid and cytopathio effect 
(CPE) in feline cell cultures and thus are easily distinguished from
feline herpesviruses which induce a slower CPE with syncytia formation 
and Cowdry A intranuclear inclusion bodies. The feline reoviruses cause 
a slow OPE characterised by ballooning and granular appearance of 
affected cells, and by the presence of large, irregularly shaped 
intracytoplasmic inclusion bodies. The whole process to its terminal 
stage of complete CPE requires 12-15 days for the reoviruses, compared 
to 1-5 days for the feline caliciviruses.
The signs of FCV disease vary markedly from inapparent infection 
involving only the upper respiratory tract to severe respiratory disease 
with pneumonia and terminal death (Kahn & Gillespie 1971)• Cats that 
recover from the disease often become carriers and persistent shedding 
of the virus from tonsilar tissues for at least eleven months (Povey 
& Johnson, 1970) is perhaps the principal means by which the virus is 
maintained naturally.
Properties of feline calicivirus
The morphology of FCV is distinctive, the particles having a 
fringe-like and 'chunky' arrangement of the capsomeres creating an 
easily recognisable pattern after negative staining (Zwillenberg &
Burki, 1966; Almeida et al, I968; V/awrzkiewicz, Smale & Brown, 1968). 
Although the capsomeres have been variously described as 'surface spikes' 
(Zee et ad, I968) or rod like (Strandberg, I968), it was V/awrzkiewicz 
et al (1968) who first identified their true structures as hollow and 
cup-like, rather like the calyx of a flower from which the generic 
name "calici" is derived. Each virion is thought to consist of 52 
capsomeres (Zwillenberg & Burki, I966; Almeida sd, 1968).
Estimation of the particle size has been made by filtration 
(Burki, 1965; Crandell, I967) and by electron microscopy (Zwillenberg 
& Burki, 1966; Almeida e_t I968; Strandberg, I968) and it is 
generally agreed that the virus has a diameter of 55-4Cmm which makes 
the virus the largest of the picornavirus group.
Physico-chemical properties
The virion of FCV is non-enveloped and icosahedral in shape 
containing an infectious single-stranded ribonucleic acid (RITA) 
(Adldinger £t I969) with a chemical composition of 29'5^ adenine, 
19*9% cytidine, 21'0^ -o guanine and 29*8^ uridine (Newman et ad, 1975).
The virions contain 18^ 6 RNA of molecular weight 2*8xlo6 and 80^ 
protein of molecular weight 12*4x10^ so that the total virion mass is 
15*2x10^ daltons (Burroughs at ad, 1978). The buoyant density of the 
virion in caesium chloride (CgCl2)i8 1*56 - l'59g*cm"^ (studdert et al,
1970» Neiman ^  ad, 1973)- It is resistant to ether or chloroform 
treatment (Burki, I966; Bartholomew & Gillespie, I968) and labile at 
pH 3 but not at pH 7 (Oglesby ^  ad, 1971). The virion is not 
stabilized by IM MgCl2 (Crandell, 19&7; Studdert ^  ad, 1970) which 
instead, enhances thermal inactivation (Kahn & Gillespie, 1970). 
Furthermore, FCV can remain infective at -65^G for at least four years 
and is able to withstand the process of lyophylization (Gillespie &
Scott, 1973).
Classification of small RNA-containing viruses
The International Enterovirus Group as part of a goal of 
classifying major groups of viruses on the basis of common biochemical 
and biophysical properties, defined a class of small RITA-containing 
viruses which they called "picornaviruses" ("pico" meaning very small 
and "RNA" referring to the type of nucleic acid in the virion) (Melnick 
et al, 1963) This group was defined to include those viruses which are 
small in size (l5-$0mm in diameter), bear no essential lipid envelope 
and contain single stranded RNA. On this basis, the picornavirus group 
ought to include the plant and bacterial small RNA viruses with which 
they have much in common. It did not; and the term 'picornaviruses' came 
to be applied exclusively to the small RITA-containing viruses that infect 
vertebrate hosts.
The International Committee on Viral Nomenclature recognised 
three genera in the family Picornaviridae; the Caliciviruses,
Rhinoviruses and Enteroviruses (Wildy, 197%). Feline calicivirus together 
with vesicular exanthema virus (VEV) of swine were placed in the genus 
Calicivirus.
This classification soon ran into difficulties. By the Committee's 
definition, the caliciviruses by virtue of their large size (35-48mm in 
diameter) should not be included in the group, while certain physico­
chemical properties suggest that foot-and-mouth disease virus and equine 
rhinovirus should not have been included in the rhinovirus genus. 
Similarly, the marked instability of the cardioviruses at pH 6 in the 
presence of chloride or bromide ions indicates that the members of this 
group are not typical enteroviruses (Speirs, 1962; Iferk, O'Callaghan & 
Colter, I97O; Bunker & Ruekert, 1971). Hence, Newman jet ^  (1973) 
suggested a division of the picornaviruses into six comprising the 
entero, cardio, calici, human rhino, equine rhino and foot-and-mouth 
disease virus subgroups.
At present, there is strong evidence that caliciviruses should 
he excised from the picornaviridae family to form a new virus group 
(Burroughs £t al> 1974; Black & Brown, 1975/76). This proposal stemmed 
from the distinctive ultrastructure, certain physicochemical properties 
and mode of replication of caliciviruses which are quite different from 
the picornaviruses. It is interesting to note that this proposal 
already has the backing of the Study Group on Picornaviruses which is 
a subcommittee of the International Committee of the Taxonomy of 
Viruses (Melnick et 1974).
Relationship of FCV to other small RITA-containing viruses
Despite unique ultrastructural and certain physicochemical 
properties, FCV is similar in many respects to other small RNA- 
containing viruses found in other animal (vertebrate and invertebrate), 
plant and bacterial hosts. Tables 1.1, 1.2 and 1,3 contain details of 
comparative properties.
Viral RNA FCV, in common with other picornaviruses, has only one 
species of virion RNA (Brown, Newman & Stott, 1970). This is also true, 
of all the small RNA-containing bacterial viruses and several of the 
plant viruses although members of the coiypea mosaic, NEPO and pea 
enation mosaic virus groups have two RNA species both of which are 
essential for infection (Van Kammen, 1967; 1968; Diener & Schneider,
1966; Harrison, Murant & Mayo, 1972). Some others like the alfalfa 
mosaic. Brome mosaic and Cucumber mosaic virus groups each have four 
or more RITA species (Kaper, I968) and in most cases these split genomes 
exist as separate molecules of varying lengths and are bacillifcrm in 
shape (Hull, Hills & Markham, I969).
Capsid components However, despite the great variation in their 
structural arrangements, all small RNA-containing viruses appear to 
possess icosahedral symmetry. The virions of most have diameters in 
the range of 22-32nm with the exception of satellite tobacco necrosis 
virus (l7nm) and the caliciviruses (35-40nm). The large size and the 
overall shape of PCV is perhaps reflected in its high sedimentation 
value of 160-2072 (Wawrzkiewicz ejt I968; Oglesby at aJ, 1971) 
compared with I4O-I6OS obtained for other picornaviruses (Rueckert, I97I; 
Newman et al, 1973), RÎ^ A bacteriophages sediment between 71-84s in CsCl2 
gradients (Watanabe £t al, I967; Kaper, I968; Bendis & Shapiro, 1970; 
Hohn & Hohn, 1970).
Purification of small RNA viruses from infected cells by sucrose 
gradient or CgClgequilibrium ultracentrifugation reveals a considerable 
degree of difference in the number of sedimenting components.
TABLE 1.1
COWARATIVE PROPERTIES OP SMALL RNA-CONTAINING VIRUS PARTICLES
No. of 
Group Sedimenting 
Particles
S-va lue /âîNA Density
(g.cm“^)
Diameter(nm)
Vertebrate Viruses
Entero 2 160, 74 50, 0 1-34, 1.50 28
Cardio 1 160 51 1-34 28
Calici(PCV) 2 170, 15* 18, 0* 1-39, 1"26* 35-
Human rhino 2 155, 75 30, 0 1-40, 1*29 28
Equine rhino 1 150 NA 1-45 28
Foot-and-mouth 2 146, 75 51, 0 1*43, 1 '50 24
disease (PMD)
Invertebrate Viruses 
Acute paralysis
of bees NA 160 NA 1-34 29
Sacbrood NA 160 NA 1*34 29
Gonometa NA 160 NA 1*34 29
Nodamura NA 140 NA 1-34 29
Plant Viruses 
Brome Mosaic
Virus (BMV) 1 87 22 1*36 26
Cucumber 
Mosaic (CMV) 1 99 19 1-37 28
Turnip Yellow 
Mosaic (TYM) 2 116, 53 34, 0 1*42, 1-29 28
NEPO 3 126,91,
53
35,25
0
1*51, 1*42 
NA
27-5
Alfalfa Mosaic 
(AMV)
4 99, 89, 
75, 68
18,18,
18,18
1-39 Bacillifoim
structure
Bacterial Viruses
RI7 1 80 30 1*46 25
GA 1 76 NA 1-44 NA
ftyS 1 84 30 1*47 25
0Cb^ 1 71 NA NA 23
Main source of information ; Brown & Hull (1975) 
NA = Not available 
* = Information from present study
TABLE 1.2
COMPARATIVE PROPERTIES OF RIBQinjCLBIC ACIDS 
OP SMALL RRA-CONTAINING VIRUSES
Group
No. of
Species S-value
Molecular weight 
CxlO"^)_________
Vertebrate Viruses
Entero 1 53-55 2*6
Cardio 1 55 2*6
Calici 1 57 $•0
Human rhino 1 52-55 2*2
Equine rhino 1 55 2*6
PMD 1 55 2-6
Invertebrate Viruses
Acute panalysis 1 50 2*0
Sacbrood 1 55 2*6
Gonometa 1 NA NA
Nodemura 2 22,15 1-0,0*5
Plant Viruses
mrv 4 27,22,14 1*09,0*99,0*75,0*28
CMV 4 25,20,1$ 1*25,1*19,0*96,0*50
TYMV 1 50 2*0
NEPO 2 52,24 2-5,1-4
AMV 4 24,22,20,1$ 1*27,1-0,0*76,0*$$
Bacterial Viruses
R17 1 26 1*1
GA NA NA NA
T 1 52 1*1
Qobg 1 50 NA
îfein source of information : Brown & Hull (1975)
NA “ Not available
Abbreviations as in Table 1,1
'Pull* viral particles contain RNA and are infectious and 
sediment faster in rate zonal gradients than the 'empty' particles, 
which have a lower buoyant density, lack RNA and are non-infectious.
All the small RNA bacteriophages R17, GA, Q,p, Oc^5 (V/atanabe 
ejt aJ, 1967; Kaper, I968; Rendis & Shapiro, 1970» Hohn & Hohn, 1970), 
the cardio and the equine rhinovirus groups of picornaviruses have one 
homogenous population of sedimenting particles (Rueckert, 1971» Newman 
^  1975). However, the enteroviruses, human rhinoviruses and foot-
and-mouth disease virus all have two sedimenting components: the 
'empties' have an S-value of 74-75s and are procapsids. This differs 
significantly from the slower sedimenting components found in the 
present study of feline caliciviruses which are not procapsids but 
unassembled virus subunits sedimenting at about 15s.
Among the plant viruses, cucumber mosaic, tobacco necrosis and 
southern bean mosaic viruses have single sedimenting components whereas 
some others have two (turnip yellow mosaic and pea enation mosaic 
viruses); even more than four have been found in alfalfa mosaic virus 
(Kaper, I968; Hull, I969).
Capsid proteins
With the exception of the caliciviruses which contain one major 
polypeptide with a molecular weight of 65,000, the picornaviruses 
examined so far contain four polypeptides (Burroughs ^  ad, 1974)» 
However, like FCV, most plant small RNA viruses have single polypeptides; 
cowpea mosaic virus, broad bean wilt virus and tomato bushy stunt virus 
are among those having two capsid polypeptides but none is knovm to have 
four (Kaper, I968),
The only analyses of the polypeptides of the invertebrate viruses 
available so far are for Gonometa virus, with four polypeptides 
(Longworth et 1975)» and Nodamura virus which has one major and . 
traces of two minor polypeptides.
All the HÎTA bacteriophages contain two or more polypeptides 
(Kaper, I968; Rendis & Shapiro, 1970; Hohn & Hohn, I970).
RNA virus assembly
In an infected cell, the virus-specific proteins and nucleic 
acid are synthesized separately and consequently must be brought 
together and assembled into mature viral particles. The mechanism of 
assembly of these particles from progeny RNA and protein is not known 
with any certainty and no work has yet been done on FCV in this 
direction* Most information is available on poliovirus (Phillips, I969;
TABLE 1.3
Group
COMPARATIVE PROPERTIES OF CAPSID PRQTEIITS 
OF SMALL RNA-CONTAINING VIRUSES
No. of Molecular weight No. per
Proteins____ (xlO"^)________________capsid
Vertebrate Viruses
Entero 4
Cardio 4
Calici 1
Human rhino 4
Equine rhino NA
PMD 4
$6,28,26,8 
$4,30,2$,9 
68 
$6,27,54,8
NA
54,50,$6,1$.5
60,60,60,$0 
60,60,60,60  
180
60.60.60,$0
NA
60.60.60,$0
Invertebrate Viruses 
Gonometa 
Nodamura 1 major
2 minor
$6*5,$2,29,15  
46, NA
NA
180
Plant Viruses 
BMV 
CMV 
TYM\r 
NEPO 
AMV
1
1
1
1
1 Or 2*
20
$2 Or 24*
20
57
$0 Or 24*
180
180
180
60
180,150,114,96
Bacterial Viruses
R17
GA
Gcb^
2
NA
5
2
15-7, 58 
NA
14,35,39
12,40
180, 1 
NA 
NA 
180, 1
Main sources of information : Brown & Hull (1975) 
* = Information still in dispute 
NA *= Not available 
Abbreviations as in Table 1,1
Jacobson & Baltimore, I968), Jacobson & Baltimore (1968) suggested that 
the empty 743 particles are the precursors of the mature virus particles, 
and that in some way, still unknown, the RNA is incorporated later into 
the already formed capsid. However, such a mechanism is not applicable 
to RNA bacteriophages (Valentine et aJ, 19^9) in which, although empty 
capsids are found, they are merely by-products and not essential steps 
on the pathway to the mature virus particle. Reconstruction experiments 
suggest that a maturation protein is involved at the early stage of the 
phage assembly.
Not much is known about the maturation of plant virus particles 
although some workers tend to favour a mechanism of spontaneous self- 
assembly and have been able to demonstrate such a process in vitro 
(Lebeurier et al, 1971)• Absolute proof of self-assembly requires that 
purified nucleic acids and structural protein (s) be able to combine 
in vitro to yield particles which resemble the original virus in shape, 
size and stability as well as being infectious. This has been shown 
for cowpea chlorotic mottle and alfalfa mosaic viruses by using protein 
and a wide variety of polyanionic nucleating agents (Bancroft, Hiebert 
& Bracker, 19&9; Lebeurier et al, 1971)*
The present study
When compared with other picornaviruses, e.g. poliovirus, foot- 
and-mouth disease virus or some cardioviruses, very little work has 
been done on the molecular biology of caliciviruses. The aim of this 
study, therefore, was to extend our knowledge of the structure and 
assembly of the feline calicivirus particles. There were four main aims.
The first was to determine whether the viral capsid was 
constructed from subunits. This was investigated by exposing purified 
PCV virions sequentially to low pH, reducing agents and denaturing 
conditions and analysing the resulting components at each stage by rate 
zonal centrifugation, polyacrylamide gel electrophoresis and guanidine 
hydrochloride-agarose chromatography. The nature of a "naturally 
occurring" FCV subunit, which was discovered in this study, was also 
investigated in this way.
Secondly, the assembly of FCV particles from smaller protein 
components was investigated. The effect of the protein synthesis in 
FCV-infected cells was studied. At a period after infection when the 
rate of FCV-specific protein synthesis was maximum, and cellular 
protein synthesis was minimal, the assembly of the FCV virion was examined, 
This was achieved by exposing FCV-infected cells to high concentrations
of radioactive amino acids for very short periods so that newly 
synthesized viral protein was radiolahelled. The label was then removed 
and the fate of the virus-specific protein was followed from synthesis 
to final incorporation into complete viral particles. It was hoped to 
relate the intermediate components found in the assembly of virus to 
the subunits resulting from■breakdown of whole particles.
The third aim was to investigate the antigenic determinants of 
the FCV virion and its subunits. Sera were prepared in rabbits to the 
virus and the major subviral component and were used in immunodiffusion 
to define the antigenic relationship of the whole virus and the subunit.
The fourth aim was to explore the possibility that the viral 
subunit, which was shown in the course of the third part of the study 
to be antigenically related to whole virus, might be used as a non- 
inf ectious vaccine against FCV infection. Cats were vaccinated with the 
purified subunit together with adjuvant and the effects of subsequent 
challenge with virulent FCV were observed.
CHAPTER 2
GENERAL MATERIALS AND METHODS
Cells
Feline embryo (FE) cells of the PEA strain (Jarrett at al, 1973) 
between 12 and 34 passages from primary culture were used in this study.
PEA cells were grown as monolayers in Glasgow modified Eagle's 
Minimal Essential Medium (MEM) (MacPherson & Stoker, I962) which was 
prepared at the Institute of Virology, University of Glasgow. Prior to 
use, the medium was supplemented with 10^ foetal bovine serum (FBS) 
(Gibco Biocult Ltd.) and is referred to as EFOqQ.
Cell growth
FEA cells (lxl07) were seeded in 2*5 litre rotating bottles with 
100ml of EFCpQ. The bottles were flushed with 5^  ^carbon dioxide in air 
and the cells were incubated at 37^0. The cells were usually confluent 
four or five days later and were removed from the glass after two rinses 
with versene (O'l^ EDTA in PBS) followed by another rinse with trypsin- 
versene mixture containing 0*255^ trypsin. The cells were resuspended in 
EFC]_o medium.
For assaying virus infactivity by plaque assay, cells were grown 
in 5cm diameter polystyrene plates (Nunclon) with 4ml of medium and were 
maintained at 37°C in an incubator with an atmosphere of 5^ carbon 
dioxide in air.
Viruses
The FCV used was the extra-large plaque (EP) type, strain Gl, 
originally isolated in this laboratory from a kitten with lingual 
ulceration (Ormerod & Jarrett, 1978).
Virus clones were produced by three cycles of growing virus from 
single plaques in plates containing only one or two plaques. After the 
third cloning the virus suspension was dispensed in aliquots and stored 
at -70°C for future stock production.
Virus stocks
Virus stock suspensions were obtained by infection of confluent 
FEA cells in 2*5 litre roller bottles at a multiplicity of infection of 
2 for 16 hours. The virus was harvested after cell debris was removed by 
centrifugation at 10,000 rpm for 10 minutes and the supernatant was 
stored in 2ml lots at -YO^C
Virus infectivity assay
Estimation of viral infectivity was determined by counting the 
number of plaques formed by dilutions of virus in confluent monolayers 
overlaid with agar.
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Monolayers of PEA cells in 5cm plates were drained of medium and 
infected with 0*lml of serial dilutions of the virus using two plates per 
dilution. The plates were gently rocked at intervals throughout a 1 hour 
adsorption period at 57°C in an atmosphere of 5^ carbon dioxide in air.
The plates were then washed twice in MEM prior to addition of m^l of 
overlay. The agar overlay consisted of 0*9^ bacto-agar (DIPCO) in MEM 
with Xfo FBS. The plates were further incubated for 48 hours before fixing 
and staining with Q*^ fo crystal violet in 10% formalin. Virus infectivity 
was expressed in plaque-forming units (pfu) per ml.
Neutralisation tests
Virus neutralising antibody was detected by a plaque reduction 
test. Neutralisation reactions were carried out in plastic microtitre 
plates (Cooke Laboratory Products). All sera were inactivated at 56^0 for 
50 minutes before use to destroy non-specific inhibitors of viral 
infectivity. Sera were diluted in twofold steps in Leibovitz (Lip) medium 
(Gibco Biocult Ltd.) using O^jjl diluters. An equal volume of PCV (LxlO^pfu/ml) 
was then added to each well.
After a reaction time of 1 hour at 57°C, 50^1 was transferred from 
each well into a bottle containing 4'95ml of L15 medium thus diluting 
the reactants 100-fold and stopping further reaction. A lOOyt/1 sample per 
dilution was assayed for residual infectivity. The serum titre was taken 
as the highest dilution which caused 95% plaque reduction of the FCV by 
comparison with 2 virus controls incubated in the same microtitre plate.
Buffer solutions
Phosphate buffered saline (PBS; Bulbecco *A') Twenty tablets of phosphate 
buffered saline (Oxoid Ltd.) were dissolved in 2,000ml of distilled water 
and autoclaved. The buffer was then dispensed in 200ml amounts and stored 
at 4^.
Tris-saline (TS) buffer A concentrated stock solution (TSxlO) was made 
by dissolving NaCl (ll6*9g), tris (24*2g) and EDTA (6*7g) in 1900ml of 
distilled water. The pH was adjusted to 7*5 with 0*1N hydrochloric acid 
and the solution was made up to 2000ml with distilled water. The solution 
was dispensed in 200ml amounts, autoclaved and then stored at 4^0. Working 
stocks of TS buffer (pH 7*5) were prepared by diluting one volume of 
TSxlO in 9 volumes of distilled water.
Sodium phosphate buffers These were prepared as outlined in the eleventh 
edition of "Medical Microbiology" by Cruickshank (l970). Two stock 
solutions were made. A 0*2M solution of sodium dihydrogen phosphate was
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prepared by dissolving $l»2g NaH2P04»2H20 in 1000ml of de-ionized water.
A 0*2M solution of disodium hydrogen phosphate was made by dissolving 
28'59g of Na2HP04 or 71'7g of Na2HP04*12H20 in 1000ml of water. The 
solutions were then mixed in specific proportions according to the pH 
of the phosphate buffer required. The mixture was diluted to a total of 
200ml and then stored at room temperature.
Radiolabelling of virus
Confluent PEA cells in roller bottles were washed in leucine-free 
MEM (Gibco Biocult Ltd.) and were inoculated with 1ml of virus suspension 
containing 1*5x10® pfu/ml to which was added 18ml of leucine-free medium 
containing ImCi of L(4»5-3H) leucine (40-60,000mCi/m.mol) (Radiochemical 
Centre, Amersham). After incubation at 57°C for 1 hour, 1ml of PBS was 
introduced into the bottle which was then incubated for a further l6 
hours. Radiolabelled virus particles were harvested and stored as already 
described.
14c-labelled PCV particles were prepared as above, but using 50^Ci 
of L-(U-^4c) leucine ($00mCi/m.mol) in 18ml leucine-free medium and 1ml 
of virus (1*5x10® pfu/ml) as inoculum.
A sample of ^^c-ieuoine labelled enoephalomyocarditis (EMC) virus 
used for comparative studies was obtained from Dr David Prisby, Imperial 
Cancer Research Fund, London.
Radioactive sample preparation and counting
Samples of radiolabelled materials were mixed with 1ml of distilled 
water contained in polyethylene scintillation vials before adding 6m1 
of He 260 scintillation fluid (Nuclear Enterprises, Edinburgh). Radio­
activity, expressed in counts per minute (cpm), was determined in an 
Intertechnique SL40 liquid scintillation spectrometer.
In certain experiments where it was necessary to determine acid- 
precipitable counts, and in dual-labelling experiments involving %  and 
^4c, radioactivity in samples was counted following precipitation with 
trichloracetic acid (TCA). Each sample was mixed with 0'5ml containing 
lOO^g bovine serum albumin followed by 0*5ml of ice-cold 10% TCA. The 
mixture was allowed to stand at 4°C for $0 minutes and the precipitate 
was then collected by filtration on Whatman GP/C glassfibre paper. The 
filter was washed with 5% TCA and then ethanol. The filter paper was 
dried and then placed in a polythene vial. Radioactivity was estimated 
after adding 6ml of a toluene-base scintillation fluid. This fluid 
contained lOg of 2,5, diphenyloxazole (PPO) and Ig of l,4-di-2(5- 
phenyloxazolyl-benze (POPOP) in 2*5 litres of toluene. Samples were
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counted to an error of less than 1%. In double-labelling experiments 
relative amounts of and isotopes in each sample were determined 
after appropriate correction for background and spillover.
Guanidine hydrochloride-agarose chromatography
About 150ml of Sepharose CL-6B gel (Pharmacia Ltd.) was dissolved 
in 0«02M phosphate buffer, pH 6*8, mixed gently and allowed to settle at 
4°C. The supernatant was decanted and the gel precipitate was washed 
three more times in buffer to remove fine particles. Guanidine 
hydrochloride (Sigma London Chemical Co.) was added to the gel until 
the refractive index was 1*4310 which was equivalent to a concentration 
of 6M. The gel was then poured into a K 15/90 column (Pharmacia) and 
allowed to settle overnight.
Two mg of each of the marker proteins (bovine serum albumin (BSA), 
ovalbumin and cytochrome C) and Img of blue dextran 2000 were dissolved 
in 1ml of the solubilizing buffer (8M guanidine hydrochloride, O’OIM 
diothiothreitol (DTT), and 2% 2-mercaptoethanol (2-ME))and were then 
incubated at 37^0 for 3 hours before heating at lOO^C for 2-5 minutes.
The mixture was then layered on top of the gel in the column and 
the proteins were eluted at a flow rate of 5cil per hour. Fractions of 
1ml were collected using an LKB Ultrarac. The relative position of the 
void volume and the protein standards in the eluting volume were determined 
on a tlnioam SP BOOA ultraviolet spectrophotometer.
The above process was then repeated using a sample of the purified 
PCV labelled with leucine and a 100^1 sample per fraction was taken 
for radioactive estimation.
SDS - polyacrylamide gel electrophoresis
Two different methods for SDS-polyacrylamide gel electrophoresis 
(p a g e) were used in this study.
Method 1 This was a continuous phosphate buffered system described by 
Jarrett jet (1973)* The gels were mixed to give a final concentration 
of 7*5% " 10% acrylamide (BDH, electrophoretic grade), 0*575% bis- 
acrylamide, 0*1M sodium phosphate buffer, pH 7*4, 0*1% SBS and 0*5M urea. 
Ammonium persulphate and H,N,II,N-tetramethylethylenediamine (TEMED) were 
added to final concentrations of 0*07% and 0*125% respectively just 
before the gels were poured into siliconised 100mmx6mm glass tubes. A 
thin layer of water was added to keep a flat meniscus on the gels until 
polymerization was complete after which it was discarded.
The test samples, already in the solubilizing buffer which
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contained 2% SDS, 50mM DTT, 2M urea, 10% (W/V) sucrose, 2% 2-ME and 
0*001% bromophenol blue, were Incubated at 57°C for 5-5 hours prior to 
heating at 100^0 for 2-5 minutes. After cooling, the samples were gently 
layered on top of the gels held in a Shandon Southern electrophoresis 
tank, top and bottom compartments of which contained the same 
electrophoresis buffer (0*1I4 sodium phosphate, pH 7'4, 1% SDS and 
0*5M urea).
The gels were run overnight at a constant current of 2*5mA per 
gel. The gels containing the marker proteins were stained with Gooraassie 
blue for 1 hour and then destained for several hours in the destain 
solution containing 5% V/V methanol, 7*5% V/V acetic acid in water. The 
gels containing the test samples were frozen with powdered solid carbon 
dioxide and were sliced transversely into 1mm slices using a Mickle gel 
slicer. Each slice was placed in a scintillation vial containing O'^ml NCS 
solubilizer (Nuclear Chicago) which was then sealed and left at 57°C 
overnight. Six ml of toluene-based scintillation fluid was added to each 
vial and the samples were counted for radioactivity.
Method 2 The second method was the discontinuous tris-buffered system 
described by Laemmli (1970) and was done in collaboration with James C,
Neil. The method involves a stacking gel which concentrates the sample, 
and a separating gel. The separating gel was cast with a fixed concentration 
of acrylamide (7*5-15%) such that the ratio of the acrylamide to bis- 
acrylamide was J>OiO»Q, Other ingredients were 0*575M Tris-HCl buffer, 
pH 6*8, 0*1% SDS, 0*1% ammonium persulphate and 0*25% TEMED.
A layer of 5% ethanol was pipetted on to the gel surface and left 
until the separating gel polymerized. This recipe was used for slab gels 
and in each case enough space was left for a stacker gel (approximately 
10mm in length) made up of 5-5% acrylamide: bis-acrylamide (50:0*8),
0*125M Tris-H6l, pH 6'8, 0*1% SDS, 0*1% ammonium persulphate and 0*025% 
TEME3D. Perspex or teflon combs were used to prepare sample wells to the 
desired size in the stacker gel.
The solubilizing buffer used in this method contained 0*0625M 
Tris-HGl, pH 6*8, 2% SDS, 5% 2-ME, 10% glycerol and 0*001% bromophenol 
blue. This was made up as double strength and was added to an equal 
volume of sample before boiling for 5 minutes. The samples were layered 
on to the gels and run at a constant voltage of 4OV during stacking 
which was increased to lOOV later. Gels were run until the tracker dye 
was about 1cm from the end of the gel and were then removed for staining 
and autoradiography.
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staining of gels The gels were left overnight in a fix-stain solution 
of 0*0125% Coomassie blue in a 10:8:1 water methanol and acetic acid 
mixture and was followed by destaining in 5% ^/v methanol, 7*5% ^/v 
acetic acid in water.
Aut orad i ography
This was done by the method of Bonner & Laskey (1974)* Gels were 
dried under vacuum at 80-100°C on to hard filter paper (Whatman grade 182). 
As it was necessary to perform fluorography in order to detect ^H-labelled 
proteins, the gels were first dehydrated by soaking in dimethylsulphoxide 
(DMSO) then impregnated with PPO by soaking for 5 hours in a 22% solution 
of PPO in DMSO. The DMSO was removed by soaking in water and the gels 
were dried as described above. The dried gels were clamped in close 
contact with medical X-ray film (Kodak XH-1 or Kodirex) which had been 
pre-exposed to a short flash of light: this procedure makes the response 
of the film to radiography linear (Laskey & Mills, 1975)* The films were 
exposed to the gels at -70°C for periods ranging from 5 days to 4 weeks 
depending on the amount of radioactivity in the sample. The films were 
developed in a 50% solution of bromophen (Ilford) for up to 5 minutes 
and fixed in Ilford Hypam rapid fixer.
Immunoprécipitation
Immunoprécipitation was used to precipitate virus-specific 
components from infected cell extracts using cat antiviral ser*um. The 
precipitate was then washed and analysed by PAGE and autoradiography.
Infected cells were lysed with 0*5ml of 0*5% NP40 at 4^0 for 15 
minutes and were then spun at 2000rpm for 10 minutes. The supernatant was 
further treated with 0*05ml of 5% deoxycholate (DOC) also at 4^0 for 
15 minutes and centrifuged at 10,000rpm for 10 minutes.
A volume of lOy/1 of antiserum was then added to 0*5ml of soluble 
antigen preparation and incubated overnight at 4°0. Fifty jjl of protein 
A-bearing Staphylococcus aureus (prepared by James C. Neil) was added 
and the mixture was allowed to stand for another 1 hour at room 
temperature. The tertiary antigen-antibody-bacterial complexes were 
then harvested by low speed centrifugation (5000rpm for 10 minutes) 
and washed twice in lysis buffer and finally in TS. The antigen-antibody 
complexes were resuspended in lOOji/1 of solubilizing buffer and then 
analysed by PAGE and autoradiography as described above.
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CHAPTER 3
THE SUBUNIT STRUCTURE OF FCV PARTICLES
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INTRODUCTION
Crick and Watson (1956) first proposed that the simpler viruses 
were built from smaller subunit structures bonded together by repeated 
use of the same bonding contacts characteristic of, and presumably 
determined by, the protein subunit itself; and that such a superstructure 
must be of cubic symmetry. This hypothesis has since been extensively 
confirmed by X-ray crystallography (Finch & Klug, 1959) a*nd by electron 
microscopy using the negative staining technique of Horne & Nagington 
(1959)' The latter authors concluded that the poliovirus capsid was 
icosahedral with 5:3:2 symmetry implying that the capsid has 60 
identical structural subunits each about 60A  in diameter.
Several attempts to establish an acceptable architectural 
pattern for picornaviruses based on this novel concept were unsuccessful 
for a number of reasons. First, it soon became clear that the properties 
of 5:3:2 symmetry and 60A  periodicity provide insufficient information 
to define a 60 subunit structure: for example, turnip yellow mosaic 
virus with crystallographic properties similar to poliovirus had 52 
rather than 60 capsomeres (Huxley & Zubay, I96O; Nixon & Gibb, I96O;
Klug & Finch, I96O); and subsequent studies by electron microscopy 
appeared to favour 52 morphological subunits among picornaviruses (l4ayor, 
1964; Breese et ad, I965» Jamison, I969). Secondly, the picornavirus 
shell is extremely compact and seems impermeable to the negative stains 
commonly used in electron microscopy so that very little surface detail 
is revealed. The third problem is the presence of several types of non­
identical polypeptide chains in picornaviruses (Maizel, 1963; Rueckert, 
1965; Rueckert & Duesberg, I966; Jacobson & Baltimore, 1970)*
Since the theory of virus structure was generally applied to 
capsids containing a single type of subunit, the presence of multiple 
chains in an apparently simple virus immediately became the most 
intriguing aspect of picornavirus structure. There were speculations 
that the virions might be composed of pentamers of one chain type and 
hexamers or trimers of another and that the protomers might consist of 
multiple polypeptides (i*Iayor, I964).
Maizel (1965) was first to show by polyacrylamide gel 
electrophoresis that the poliovirus particle contained 4 virus capsid 
proteins (VPX-.4). Subsequently Goxsackie viruses (Crowell & Phillipson, 
1971); cardioviruses (Rueckert et al, I969) and rhinoviruses (Medapa 
et al, 1971 ; Korant _et 1972) were also reported to have four 
distinct polypeptides present in equiraolar amounts in each kind of
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virion. The only exception is the calicivirus which has only one capsid 
polypeptide (Burroughs & Brown, 1974)*
The results of virion polypeptide analysis encouraged more 
workers to carry out controlled particle dissociation with the intent 
of elucidating the architecture of picornaviruses. This idea met with 
a degree of success in certain viruses: for example, mengovirus and 
EMC virus under acid conditions were dissociated into 143 and 53 
fragments (O'Callaghan, Mak & Colter, I970)* Mouse-Elherfeld (ME) virus 
has also been similarly disrupted into I4S and 53 subunit structures, 
both containing three major polypeptides (Bunker & Ruekert, 1971)» This 
led the authors to suggest a structure with a triangulation number of 
one, containing 60 protomers (53) arranged in clusters of 12 pentamers 
(14s). A similar model was suggested for foot-and-mouth disease vims 
where the dissociation appears to occur along boundaries of the 
icosahedral facet creating a trimer of protomers (l2S) instead of 
pentamers (Talbot & Brown, 1972).
However, similar treatment of the enteroviruses, e.g. poliovirus, 
has not been quite so successful because of their acid-stable nature; in 
fact, poliovirus has not been dissected into subviral particles beyond 
the stage of the 753 empty capsids, although alkaline degradation 
suggests that both V?2 and VP4 can be sequentially removed from the 
capsid structure (Maizel £t ad, 1967; Katagiri et al, 1971).
Until now there was no evidence that caliciviruses could be 
dissociated into subunit particles. In the present study attempts were 
made to sequentially disrupt purified PCV particles, first, by acid 
treatment and then subjecting the resulting products to the action of 
reducing agents, until finally, the basic viral capsid proteins were 
produced. This procedure would not only extend our knowledge of the 
structure of PCV subunit particles but also increase the understanding 
of the possible ways in which the virions were constructed.
Also in the work described in this chapter, the effect of storage 
on purified PCV particles at different temperatures was examined and 
the results were compared to normal storage of virus working stocks.
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MATERIALS & METHODS
Virus purification
After infecting PEA cells with FCV and incubating the cultures 
for 16 hours at 57°C the virus was harvested. Cellular debris was 
removed by centrifugation at 10,000rpm for 10 minutes and to the 
supernatant fluid was added an equal volume of cold saturated ammonium 
sulphate neutralised with NaOH. The mixture was maintained at 4°C for 
5 hours and was then centrifuged at 5,000rpm for 5 minutes. The resulting 
precipitate was resuspended in I'Oml of TS and the virus was then 
purified by either of two methods.
Method 1 The resuspended material was layered in a cellulose nitrate 
ultracentrifuge tube on top of a solution consisting of l*5ml CsCl2 of 
buoyant density l*50g.cm” ,^ l'5ml 70% sucrose and l*Oml 20% sucrose.
The tube was then centrifuged in an SW 50.I rotor at 56,OOOrpm for 
2 hours. The light-scattering band which formed at the junctions of the 
CsCl2 and the 70% sucrose layer was collected after puncturing the 
bottom of the tube. This material was then diluted in TS and layered on 
a 4*5®1 column consisting of l*5ml, l*5ml and I'Oml of CsCl2 solutions 
of buoyant density 1*50, 1*50, and l*15g.cm“  ^respectively. This was 
then centrifuged in an SW 50.I rotor at 40,000rpm for I6 hours. The 
viral material was recycled once more, and the gradients were fractioned 
using a Buchler fraction collector. A sample of each fraction was taken 
for radioactive estimation.
Method 11 This method was similar to the above except that instead of 
concentrating the virus-containing material by initial centrifugation, 
it was layered directly on a 20-70% linear sucrose gradient and 
centrifuged in an SW 50.I rotor at 45,000rpm for 50 minutes. The light- 
scattering band was recovered and the viral components were subjected 
to further centrifugation in CSCI2 gradients as described above. Virus 
infectivity assay was carried out on all the radioactively labelled 
sedimenting peaks.
Buoyant density measurement
The refractive index of every third fraction was measured using 
an Abbey refractometer (Bellingham & Stanley, London) and the buoyant 
density was calculated from a calibration curve in which refractive 
index values were plotted against their corresponding buoyant densities.
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Electron microscopy
Using the loop drop method, purified viral materials were placed 
on a 400 mesh formvar-carbon coated copper grid. The grids were washed 
twice with ammonium acetate to remove any remaining CsCl2. An equal 
volume of 5% phosphotungstic acid (PTA), pH 7*2, was applied to the 
grid which was then drained off. The grids were examined in an AEI 
EM 6B electron microscope by Dr Helen M. Laird,
Dual radioisotope labelling of virus
The dual labelling experiment was designed to simultaneously 
label both viral ribonucleic acid and proteins with radioisotopes to 
determine which of the viral sedimenting components contained RNA or 
proteins or both together.
A mixture of IraCi of ^H-leucine and 50|lCi ^4c-uridine in 20ml of 
leucine-free medium containing 1*5x10® pfu of PCV was used to infect 
a confluent 2*5 litre roller bottle of FEA cells. After 1 hour I'Oml 
of FBS was added to the inoculum and the cells were incubated at 37*^ 0 
for 16 hours. Harvesting of virus and clarification were done as 
described earlier.
Determination of sedimentation rate
This was done by rate zonal ultracentrifugation. Samples of 
200-500^1 of the test sample were layered on top of a 5ml 15-30% 
linear sucrose gradient prepared in an SW 50 tube. The tube was loaded 
on to an SV/ 50*1 rotor and centrifuged at various speeds depending on 
the sample under investigation. For example, the fast sedimenting 
PCV peak was centrifuged at 45,000rpm for 50 minutes while the slower 
sedimenting viral subunits were spun at 50,000rpm for 18-24 hours.
The gradients were fractioned and analysed as described earlier. 
Preparation of IgG and 1^4 markers
About 20ml of freshly prepared calf serum obtained from 
Dr C.O, Dawson was precipitated with an equal volume of saturated 
ammonium sulphate. The precipitate was resuspended in TS buffer and 
the protein was re-precipitated with 2 volumes of ice-cold absolute 
ethanol at -20^0 overnight. The process of precipitation and 
resuspension was continued until the purity of the globulins was 
confirmed by scanning a sample of the preparation, diluted 1:100, 
at 2dOjUm in an ultraviolet spectrophotometer. A volume of 250^1 of a 
1:10 dilution of the partially purified globulin was centrifuged on 
a 10-40% sucrose gradient at 50,000rpra for 18 hours in the SW 50.1 
rotor. The gradient was fractioned and the optical density of each
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fraction was estimated at 280^ /n, Both 19S IgM and 73 IgG appeared
as well defined peaks and were then harvested and stored at -20°C,
Dissociation of FCV into 153 subunits
One volume of a purified preparation of ^H-leucine-labelled 
FCV was mixed with 4 volumes of 0*05M phosphate buffer at pH 6'5, thus 
bringing the CsCl2 concentration in the preparation to approximately 
0*7M* The mixture was then incubated at 42°C for 1 hour. The virus 
subunit generated by this treatment was isolated on a 15-30% linear 
sucrose gradient by rate zonal ultracentrifugation at 45,000rpm for 
9 hours. The sedimentation rate of the virus subunit was determined 
by using purified bovine IgM and IgG as markers. In another experiment, 
the 143 ^^C-labelled EMC virus subunit was used as marker. The marker 
was prepared by acid treatment of purified EMC virus in 0*02M phosphate 
buffer at pH 6*2 in the presence of 0*14M NaCl at 57^0 for 1 hour.
Effect of -pH on virus infectivity
A sample of 50pi of purified FCV peak 1 was diluted in I'Oml 
of 0*05M phosphate buffer and the pH was adjusted to 6*0, 6*2, 6*4»
6*5» 6*6, 6*8, 7*0 and 7*2 respectively. The samples were distributed 
in glass bottles and maintained at 42^0 for 1 hour and then allowed to 
cool to room temperature. Serial dilutions of the samples were made 
in TS buffer and assayed for infectivity.
Dissociation of the 153 component into 53 subunits
The remaining FCV 153 subunit prepared as described above was 
made up to 500pl with TS buffer and exposed to the action of reducing 
agents (lO^l 2-ME and O^pl 0*1M DTT) at 42^C for 1 hour. The resulting 
58 viral subunit was isolated on a linear 15-30% sucrose gradient by 
rate zonal ultracentrifugation at 30,000rpm for 20 hours.
Polypeptide analysis of the 58 subunit
The polypeptide composition of the 53 FCV subunit was determined 
by 6M guanidine hydrochloride agarose column chromatography.
FCV stability under storage
The stability of purified FCV stored at three different 
temperatures (4°C, -20°C and -70°C) was investigated.
A purified virus sample was made up to 24ml in TS buffer and a 
lOpl sample was taken and diluted for infectivity assay. The rest was 
dispensed in eight I'Oml samples in glass bottles and incubated at the 
various temperatures.
A bottle, stored at each temperature, was withdrawn at weekly 
intervals and subjected to infectivity assay and rate zonal ultra­
centrifugation using ^'^C-labelled 153 FCV subunit as marker.
21
RESULTS
Purification of feline calicivirus
Two methods of purification of virus were examined. Virus was 
labelled with ^H-leucine, precipitated from culture fluid with ammonium 
sulphate and treated as described above.
Method 1 Only one large peak of viral protein material was obtained by 
this method (Pig.J.l), However, on further purification of the peak by 
isopycnic centrifugation in CsCl2 , two separate and well defined 
radioactive peaks were obtained which for convenience were called 
peak I and peak II (Pig. 5.2). In terras of radioactive counts peak II 
was approximately ten times larger than peak I,
Method 2 Direct analysis of the resuspended viral material following 
ammonium sulphate precipitation yielded two peaks (peak I & peak II) 
by rate zonal ultracentrifugation in sucrose gradients (Fig, 5*3). The 
peaks were separately pooled and further purified by two cycles of 
CsCl2 centrifugation (Fig. 5*4). This method was more commonly used in 
this study because it yielded directly the two viral peaks required 
for analysis and was more rapid.
Definition of the viral protein peaks
A number of experiments were performed to define the nature of 
the two radioactive peaks.
Buoyant density FCV has a reported buoyant density of 1*56- l'39g'0m"^ 
(Newman ^  al, 1973; Studdert ejb al, 1970) and an estimate of l*59g.cm”5 
for peak I was obtained in this study (Fig. 5*4A). This compared with 
a value of l*26g.cm”  ^for peak II (Fig. 5*4B). These results suggested 
that peak I contained the complete virus.
Sedimentation rate Using purified l60S EI'IC virus as marker, peak I 
was found to have a sedimentation rate of 170S as shown in Pig. 3*5.
This is within the range of 160-207S already published for vesicular 
exanthema virus of swine, another calicivirus (Wawrzkiewicz ^  ad, I968; 
Oglesby, Madin & Schaffer, 1971; Newman et 1973). By comparison, 
using 19s bovine immunoglobulin (l^) as marker, peak II had a 
sedimentation value of 158 (Fig. 3*6).
Infectivity As shown in Fig, 5*7, virus infectivity assay revealed 
that about 99% of the infectivity was associated with peak I (Fig. 5*7A) 
compared with peak II (Fig. 5*7B).
Viral RNA The result of the dual labelling experiment showed that 
viral proteins labelled with ^H-leucine were found in both peaks I and II, 
whereas the from radiolabelled uridine was found only in peak I 
(Fig. 3.8). This suggested that peak I contained RNA and peak II did not.
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3H-leucine labelled FCV was precipitated by ammonium sulphate 
and the resuspended precipitate was centrifuged as described above 
in the SW 50.1 rotor at 56,000rpm for 2 hours. Samples of 10^1 from 
each fraction were assayed for radioactivity.
Figure 5.2 Purification of FCV by Method IsII
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The peak shown in Fig. 5.1 was diluted in TS buffer and centrifuged 
on a CsClg gradient in an SW 50.1 rotor at 40,000rpni for l6 hours. 
The radioactivity in 20^1 samples of each fraction was determined.
Flfflire 3o3 Purification of "FCV "by Method 2:1
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Preliminary purification of PCV by rate zonal ultracentrifugation 
in 20-»70/^ sucrose gradient after ammonium sulphate concentration. 
The SW 50*1 was centrifuged at 45,000rpm for 30 minutes.
Fiftiire 3<>4 Purification of FCV "by Method 2:11
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Recycling of peaks I and II shown in Fig. 5»5 on GsGlg gradients in 
the SW 50*1 rotor at 40,000rpm for l6 hours.
Figure 3*3 Determination of the sedimentation rate of FCV
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Sedimentation was in 13-30^ sucrose gradient in the 
SW 30*1 rotor at 45,000rpm for 30 minutes.
Fiffure 3 » 6 Determination of the sedimentation rate of
FCV subunit (peak II)
12
19s
IgM
0*46
15s FCV
subunit
0*42
o.
CO
FRACTION NO
o
CO
CNi
oo
U)
Sedimentation was in a 15-50^ sucrose gradient in the 
SW 50-1 rotor at for 5 hours.
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The sample was centrifuged in CsCl2 gradient in 
SV/ 50*1 rotor at 36,OOOrpm for l6 hours. Samples 
of 20|jl from each fraction were assayed for 
radioactivity.
Electron microscopy Characteristic PCV particles were found in peak I 
after negative staining (Plate 3.I). By contrast, peak II contained a 
large mass of unidentified homogeneous material among which were a few 
virus particles (Plate 5*2).
All the above results confirmed that peak I contained the 
infectious virus. This posed the question of the nature of the material 
contained in peak II. This was investigated in two ways; first, by 
comparison of the molecular weight of the protein of peaks I and II; 
and secondly, by antigenic analysis as discussed in Chapter 5* 
Polyacrylamide gel electrophoresis of viral components
One of the unique properties of FCV is that it has only one 
major capsid protein (Bachrach & Hess, 1975; Burroughs & Broim, 1974). 
Advantage of this feature was taken to analyse samples of peak I (virus) 
and peak II for their protein constituents by polyacrylamide gel . 
electrophoresis and it was found that both contained a single major 
polypeptide of molecular weight 65,000 (Pig. 5*9)•
Possible source of the 15S subunit in virus harvests
This result suggested that peak II contained virus-specific
material, possibly viral subunits which were not incorporated into whole
virus during virion assembly. Alternatively, peak II might be an artificial 
product resulting from: a) the long period of virus production (I6 hours), 
since the reproductive cycle of the virus is completed by 6 hours; b) the
effect of temperature (57°C) and pH (6*6) during incubation; or c) the
viral subunits might be generated by centrifugation during purification.
These points were investigated as follows.
Effect of time on virus production FCV was harvested from FEA cells 
infected 6, 9 and 24 hours after infection and then analysed for peaks 
I and II. It was found that there was as much peak II in the 6 hour 
harvest as there was in the 9 hour and 24 hour harvests (Fig. $.10),
This meant that the time of virus production has no effect either on 
the yield or on the quantity of peak II produced.
Effect of temperature (37°C) and pH (6*8) In a reconstruction
experiment the stability of purified peak I FCV added to EFCqo medium 
of pH 6*8 and incubated at 37°C for 16 hours was examined. These were 
the conditions under which the virus was normally produced. After 
incubation, the virus suspension was analysed on CSCI2 gradients to 
detect if any peak II had been generated. The result (Fig. 3.II) 
showed that under these conditions peak I FCV remained stable.
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Plate 3.1 Electrorunicrograph of peak I
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Plate 3.2 Electronmicrogratf■ of peak II
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Figure 3,9 Polyacrylamide gel electrophoresis of FCV peaks I and II
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Centrifugation was on CSCI2 gradients in the SW 50.1 rotor at 40,000rpin 
for 1 6  hours. Samples of 20 j^l from each fraction were assayed for 
radioactivity.
Figure 3.11 Effect of temperature and pH on FCV components
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Sedimentation was in 15-5C^ sucrose gradient in the SW 50,1 rotor 
at 45yOOSrpm for $0 minutes, Sê 
were assayed for radioactivity.
. amples of 25|/1 from each fraction
Effect of centrifugation Samples of a feline calicivirus preparation 
obtained following ammonium sulphate precipitation were centrifuged on 
CsCl2 gradients in the SW 50*1 rotor at 36,000rpm for 3, 6 and 24 hours 
to see how centrifugation might effect the integrity of the virus. 
Figure $.12 shows that centrifugation per se did not dissociate the 
virus into subunit structures.
From these results, it was concluded that the 15S components 
which constitute the so-called peak II are not artificial products but 
possibly unassembled viral proteins found in infected cells,
FCV particle dissociation
Generation of a 15S component Using bovine IgG and Igfl (Fig. 3-13) or 
14s EMC virus subunit (Fig, 3*14) as markers, it was found that acid 
treatment of FCV dissociated the virus into I5S subunit. Oglesby e_t ^  
(1971) found that a 2M concentration of CSCI2 was deleterious to the 
integrity of vesicular exanthema virus (a calicivirus), so that the 
presence of 0»7M CSCI2 in this reaction, therefore, probably aided FCV 
dissociation. Furthermore, the artificial 15S subunit labelled with 
14c-leucine co-sedimented with the naturally produced subunit (peak II) 
labelled with ^H-leucine in sucrose gradients by rate zonal ultra­
centrifugation (Fig, 3,15) suggesting that both might be identical. 
Generation of a 58 component When exposed to the action of reducing 
agents, such as 2-mercaptoethanol (2-MS) and DTT as was used in this 
study, the I5S viral subunits dissociated into smaller 5S subunits.
This was observed for the "natural" (Fig. 3.16) and "viral" (Fig, 3.17) 
15s subunits. This sequential breakdown of virus particles provides 
experimental support for the hypothesis that the calicivirus particle 
is held together by (at least) two different types of inter-subunit 
bonds.
Polypeptide analysis of the 5S subunit
The polypeptide content of the 5S subunit was analysed by 
guanidine hydrochloride-agarose column chromatography and the result 
showed that it contained a single major polypeptide with a molecular 
weight of 65,000 (Fig. 3*10)* Also seen was a minor polypeptide of 
molecular weight 13,500 daltons which might be similar to that found 
by Burroughs & Brown (1974) by polyacrylamide gel electrophoresis. 
Bachrach & Hess (1973) found a similar component in radiolabelled but 
not in stained gels and suggested that it could be either viral or a 
contaminant. However, detailed investigation in this study by poly­
acrylamide gel electrophoresis and autoradiography seem to support the 
presence of a minor polypeptide in FCV (see Chapter 4 ),
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Effect of centrifugation time on FCV
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Samples of FCV preparation following ammonium sulphate precipitation 
were centrifuged in the SV/ 50*1 rotor at 40,00Orpm for 6 and 24 hours
Figure 3.13 Sedimentation behaviour of a FQV subunit obtained 
by acid dissociation
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The sedimentation value of 15S FCV subunit was determined in a 15-50% 
linear sucrose gradient centrifuged at 45yOOO%pm for 9 hours in 
SW 50»1 rotor using bovine 198 IgJ'î and 78 IgG- as markers®
Figure 3.14 Sedimentation rate of the PCV subunit
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^‘^C-labelled EMC virus was used as marker. The mixture was sedimented 
in linear sucrose gradient at 30,000rpin for 20 hours. Samples
of 20|jl from each fraction were assayed for radioactivity.
Fi^-ure 3«15 Sedimentation behaviour of the natural and artificial
158 FCV subunit particles
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The samples were centrifuged in 15-50^ sucrose gradient in SW 50.1 
rotor at 50,000rpm for l6 hours. 20^1 samples from each fraction 
were assayed for radioactivity.
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Sedimentation was in 15-30^ sucrose gradient in the SW 50»1 rotor 
at 30p000rpm for 20 hours.
Figure 3»17 Dissociation of the viral 15S subunit into 
a 5S component
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Centrifugation was as in Fig. J>ol6,
Polypeptide composition of the subunit
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Analysis was by 6M guanidine hydrochloride agarose column 
chromatographyo
Effect of varying pH on virus infectivity
This experiment showed that below pH 7*0 dissociation of virus 
occurred to such an extent that most infectivity was lost, whereas at 
pH 7*0 and above, the integrity of the virus as well as infectivity 
remained relatively stable. The result showed that the exposure of FCV 
to phosphate buffers of varying pH at 42°C for 1 hour resulted in the loss
of infectivity of more than 5 logs at pH 6*5 and of about 4 logs at pH
6*0. Within the same period infectivity remained relatively stable in
particles exposed to pH 6*8 - 7*2 (Fig. 3•19)»
Stability of virus on storage
The result of this study showed that freezing at -70^0 has a 
devastating effect on purified FCV. It was found that after three weeks 
of storage at -70^0 (Fig, 3*20) almost all infectious virus had converted 
to the 15s virus subunit and infectivity had dropped by about four orders 
of magnitude (Fig. 3*23). The samples stored at -20^C remained appreciably 
unaffected for the first 3 weeks after which the virus rapidly 
dissociated (Fig, 3*21) and infectivity tailed off accordingly so that 
by six weeks infectivity had dropped by more than three log units 
(Fig. 3.23).
However, the best method of storage was at 4^0: even after 8 weeks 
virus dissociation (Fig, 3*22) and loss of infectivity (Fig. 3*23) was 
minimal at this temperature.
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Figure 3,20 Effect of storage at -70°0 on purified FCV
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DISCUSSION
In harvests of FCV, following several cycles of growth in PEA 
cells, two homogeneous populations of viral components with different 
buoyant densities were observed after centrifugation in CsClg gradients. 
The first component, with a buoyant density of l*59g»cm"^, contained 
RNA, was infectious and had a sedimentation value of 17OS, This was the 
PCV particle. The second component, which appeared to contain ten times 
as much viral protein as the first, had a density of l'26g,cm"^, did 
not contain RNA and was of low infectivity. It had a sedimentation 
value of 15s and was identified as a viral subunit.
Similar non-infectious virus-specific particles lacking nucleic 
acid and infectivity have been encountered during the purification of 
enteroviruses including poliovirus (Mayer et al, 1957» Scharff &
Levintow, I965), various Goxsackie viruses (Schmidt at af, 1963; 
Frommihagen, I969) ECHO viruses (llalperen, I964; Fabiyi et al, I964), 
foot-and-mouth disease virus (Breese, I968) and several other small 
RNA-containing plant and animal viruses (Kaper, I96O; Rhim, I96I;
Longley & Leberman, I966).
The non-infectious components of poliovirus (Penman, I964), 
foot-and-mouth disease virus (Breeso, I968) and human rhinoviruses 
(Brown & Hull, 1973) contain empty viral procapsids which sediment at 
75s. This is remarkably different from cardiovirus (Scraba & Colter,
1974) and equine rhinoviruses (Brown & Hull, 1975) preparations which 
lack this component, or PCV which has now been shown in this study to 
have a component sedimenting at I5S (rather than 75S) and containing 
viral subunits instead of procapsids.
Although it has been suggested by Jacobson and Baltimore (1968) 
that the 75S procapsid represent an intermediate structure in the 
morphogenesis of poliovirus, the lack of it in several other picornavirus 
systems tends to indicate a different morphogenic pattern from the 
polioviruses.
With reference to the above, the particle dissociation experiments 
were done to provide information on the various intermediate subunit 
structures that might be involved in PCV assembly; and it was found that 
under controlled conditions the virus dissociated into I5S and 5S 
subunit particles. Although as detailed above, FCV differs significantly 
in certain aspects from other picornaviruses, these results provide an 
area of congruence. For example, ME virus (Rueckert et al, I969), Mengo 
and EMC viruses (O’Callaghan, Mak & Colter, 1970) have each been
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dissociated into I4S and 5S subunit structures. Phillipson _et ad (1973) 
obtained 20S and subunits after similar treatment of Goxsackie 
virus while foot-and-mouth disease virus has also been dissociated into 
12s subunit components (Talbot & Brown, 1972). Poliovirus, by virtue 
of its acid stable property has not been dissociated beyond the stage 
of the 75s procapsid although there are reports that I4S and 5S 
poliovirus-related fragments can be demonstrated in infected cell 
extracts (Watanabe et al, I967; Phillips et al, 1968).
Also in this study, it was found that between pH 6*0 and 6*3, in 
the presence of 0*05M phosphate buffer and 0*7M GsClp, the integrity 
of FCV suffered so much that more than 5 logpQ units of virus infectivity 
was lost after incubation at 42^0 for 1 hour. This result was in 
agreement with that of earlier workers (Zee and Hackett, I967; Oglesby 
et al, 1971) who found that vesicular exanthema virus was not stabilized 
at 30^0 by various salts and in fact, inactivation was observed when 
the virus was exposed to 2M CsClp. The presence of 0*7M CsCl in the PCV 
preparation therefore, may have had some influence in the dissociation 
of the virus, A similar virus preparation kept at pH 6*8, 7*0 and 7*2 
remained relatively unaffected. It is presumed that the loss in infectivity 
was paralleled by breakdown of peak I into non-infectious I5S subunits.
These intermediate subunit particles are not only key fragments 
in deducing the organisation of the polypeptides in the capsid, they 
are also useful reference particles for evaluating the possible identity 
of biosynthetic intermediate subunits in infected extracts. Furthermore, 
they provide experimental evidence in support of the assumption that 
picornavirus, including FCV, particles are held together by two different 
intersubunit bonds: one type binding the 3S structures to form the I3S 
subunit and the other binding the I3S components together to form the 
viral shell. This hypothesis provides an integrating concept which 
suggests that assembly of the virion probably also occurs in two stages 
corresponding to the stepwise utilization of the two types of inter­
subunit bonds. The architecture of PCV in relation to other picornaviruses 
is dealt with in more detail in Chapter 4.
During the course of this study, a purified ^H-leucine labelled 
FCV was maintained at -70^G pending further analysis, but a few weeks 
later the virus was found to have lost infectivity and almost all of 
it had converted into the I3S subunit component. This discovery led to 
the study of FCV stability under storage at -70°C, -20°C and 4°C. The 
result showed that over a period of 8 weeks purified virus is best
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preserved at 4°C. This result was in contrast to normal storage of 
virus stocks at -70^0. The presence of serum proteins in the storage 
medium (Eagle's medium containing 10^ foetal bovine serum) acting as 
a cross-linking substance presumably helped to maintain the integrity 
of the virus under storage. By contrast, the purified PCV samples were 
stored in TS buffer which contained neither proteins nor other cross- 
linking reagents capable of preventing virus particle dissociation such 
as was noticed in the samples stored at -70°0 and -20^0.
The idea of using cross-linking reagents to stabilize labile 
structure has been known for some time, for example, cross-linked 
Escherichia coli 3OS ribosomal subunit retained their structural 
integrity with only a slight loss of biological activity (Sickle al,
1972). Cross-linking protected virions of cowpea chlorotic mottle 
and brome mosaic viruses from disassembly upon dialysis against IM 
NaCl at pH 7*5 (Bancroft & Smith, 1975)* In a recent study of the 
behaviour of cross-linked and non-cross-linked purified San Miguel 
sealion calicivirions stored at 4°C over a period of 25 weeks, Schaffer 
and Soergel (I976) found that the integrity of the cross-linked sample 
remained stable whereas about half the non-cross-linked sample had 
already dissociated. In the interest of long term storage of purified 
PCV however, it would perhaps be best to consider using a cross- 
linking reagent such as dimethyl suberimidate although for short term 
purposes, storage at 4°C would be adequate as shovm in this study.
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CHAPTER 4
THE ASSEI^ IBLY OP FELII'fE CALICIVIRUS PARTICLïS
29
INTRODUCTION
In the previous chapter, two viral suhunit structures obtained 
by dissociation of PCV particles were described and were considered 
to be possible intermediates in the maturation pathway of virions 
of PCV.
Experimental evidence in support of this assumption has been 
provided by the results of studies on other small RNA viruses. Por 
example, two capsid-related subunits sedimenting at about 6S and I4S 
have been identified in extracts of EMC virus-infected Krebs ascites 
tumour cells (Kerr _et I965). Similarly tv/o poliovirus-related 
fragments sedimenting at 4S and 748 have been described in poliovirus 
infected cell extracts (Phillips I968), and kinetic labelling
experiments in vivo (Penman, I964; Jacobson & Baltimore, 1968a) 
suggest that these are sequential precursors of the mature virion 
because, under certain conditions ^  vivo, radioactive label from 
74s empty procapsids can be chased into virions (Jacobson & Baltimore, 
1968a)• At the commencement of this study nothing was known about the 
assembly pathway of caliciviruses. The aim of the work described in 
this chapter was to examine the vivo assembly of PCV.
Picornaviruses are thought to have monocistronio messenger 
RNA: that is, all the virus-specified proteins found in picornavirus 
virions and in infected cells arise by cleavage of a single polyprotein 
that represents the total information of the viral genome. Recent 
studies on the biosynthesis of poliovirus suggest that the viral RNA 
genome is translated into a single large polypeptide (non-capsid viral 
protein - NCVP-OO) with a molecular weight of about 200,000-260,000 
(Jacobson & Baltimore, 1968b; Kiehn & Holland, 1970) which is then 
cleaved to form a smaller chain (ilaizel & Summers, I968; Holland & 
Kiehn, I968), This chain (NCVP^), of molecular weight about 100,000, 
has been identified in extracts of cells infected with poliovirus 
(Jacobson _et 1970; Cooper _et 1970) or EHC virus (Eutterworth
^  1971).
There is evidence (Jacobson & Baltimore, 1968b. Summers &
Maizel, I968) to support the hypothesis that the NGVP% is the 
progenitor of procapsid proteins (Pig. 4*l)* First, by the use of 
amino acid analogues which arrested the cleavage of the polyprotein, 
the procapsid proteins (VPo, VPl & VP5) were not formed. Secondly, in 
pulse-ohase experiments the loss of label from newly synthesised
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Fifflire 4°1
CSeavages of PoSiovirus Proteins
mRNA
NCVP OO
NCVPq
VPVR NCVP.2
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This diagram shows the post-translational cleavage of poliovirus 
proteins. It is suggested that the viral RNA directs the synthesis 
of a single protein (nCVPo o) which is cleaved in steps to generate 
virus capsid proteins and several other non-capsid polypeptides.
Double arrows indicate cleavages for which evidence is 
strong and single arrows indicate events for which there is weaker 
or little experimental evidence (Jacobson and Baltimore, 1968b),
NCVP^ vas paralleled by a quantitative increase of radioactivity in 
the capsid proteins. This cleavage mechanism, therefore, appears to 
play an important role in the formation of most, if not all, virus- 
specific proteins of poliovirus and indeed all picornaviruses.
While picornaviruses exhibit translation of a monocistronio 
messenger RNA as a pre-requisite for replication, PCV appears to have 
a completely different strategy. Black and Brown (l9T5/?6) found 
that during the replication of caliciviruses the only virus-specified 
polypeptide synthesized was the structural capsid protein (p65) and 
synthesis of this protein did not appear to involve either precursors 
or proteolytic cleavage. In their later work these authors were able 
to demonstrate the synthesis of two additional polypeptides of 
molecular weight 80,000 and 100,000 in cells infected with VEV or PCV 
(Black & Brown, 1977), Again, pulse-ohase experiments failed to 
demonstrate any precursor-product relationship between the three 
polypeptides. The use of protease inhibitors further showed that the 
synthesis of plOO, p80 and p65 was independent of each other.
Using the slab gel electrophoresis and autoradiography techniques 
experiments were carried out in this study to examine the sequence of 
polypeptide synthesis in PCV-infected cells with particular attention to 
the presence of any large molecular weight capsid protein precursors. 
These were designed as follows:
1) Total proteins (pre-existing and newly synthesised) present in the 
cells at 50 minute intervals throughout the growth cycle were analysed 
by polyacrylamide gel electrophoresis and staining of the gels.
2) Newly synthesised proteins were investigated by analysis of the 
polypeptides which became labelled with ^H-leucine during each 30 
minute interval,
5) Newly synthesised virus-specific proteins were selected by immuno­
précipitation and were analysed by polyacrylamide gel electrophoresis 
and autoradiography.
The occurrence of possible larger virus-specific subunits was 
also examined by radiolabelling cells infected with PCV for a short 
period (the pulse) and subsequently incubating them in radioisotope- 
free medium (the chase). At intervals during the chase the appearance 
of subviral components was analysed by rate zonal ultracentrifugation.
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MATERIALS A^ ID METHODS
Protein synthesis in FCV-infected cells
Twelve 5cm polystyrene plates, each containing 4 sterile 
round coverslips of 10mm diameter, were seeded with 10^ PEA cells 
and incubated overnight at 57°0. Six of the plates were kept as 
controls while the remainder were each infected with PCV at a 
multiplicity of about 100 for 30 minutes. The inoculum was then 
removed and the monolayers were washed twice with PBS and re­
incubated in EPC%o at 37°C.
After 30 minutes, and at 50 minute intervals thereafter until 
240 minutes post-infection, two infected and two uninfected cover­
slips were withdrawn into separate plates, incubated in leucine-free 
MEM for 5 minutes and labelled for I5 minutes with lOOyxl of leucine- 
free medium containing lOyj^ Ci of ^H-leucine, The coverslips were then 
washed with, consecutively, 10^ TCA, jfo TCA, distilled water and 
ethanol and were then left to dry. Each coverslip was placed in a 
scintillation vial with 6m1 of toluene-based scintillation fluid 
and the radioactivity was determined. The amount of protein 
synthesised during each 15 minute period of labelling was taken as 
the average of the radioactive counts of the two coverslips used at 
each time point.
Simultaneously, plates containing PEA monolayer cells were 
infected as above and at the same intervals after infection one plate 
was withdrawn and the cells were lysed with 0'5ml of 0*5% 40 and
O'5^ DOC. A sample of 50yLtl of each lysate was assayed for virus 
infectivity by the plaque assay method. The remaining lysate was 
divided into two parts: one was analysed for total (i.e. cellular 
and viral) proteins and the other for virus-specific proteins by 
immunoprécipitation using the method described in Chapter 2,
Pulse-chase experiments
After 30 minutes infection and a further incubation at 37*^ 0 for 
150 minutes, the infected cells in 5cm plates were starved in leucine- 
free medium for 15 minutes and labelled with 200ywGi/ml of ^H-leucine 
for periods ranging from 5 seconds to 5 minutes. The cells were then 
incubated for 5, 15, 50 or 60 minutes in 5m1 MEM containing 100-fold 
excess of unlabelled L- leucine (Cibco Biocult Ltd.),
The cells were lysed as before and 50^1 of I5S and 50 PCV 
subunits labelled with ^^C-leuoine was mixed with 20Cyi of cell
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lysate and analysed by rate zonal ultracentrifuagtion in 15-30^ 
sucrose gradients in the S\7 50.1 rotor at 50,000rpm for 20 hours. In 
some experiments a pad of 0»5nil of CsClg of density l*5g*cm“5 was 
included at the bottom of the tube to collect any fast-sedimenting 
components (e.g. I7OS whole virus). The gradients were fractioned and 
the TCA-precipitable radioactivity in each fraction determined.
Similarly, in Experiment 4 , 600^Ci of L - (^^S) methionine 
contained in 1ml of methionine-free Eagle's medium was used to pulse- 
label PEA cells infected as above. The infected cells were stored in 
methionine-free medium for 15 minutes prior to labelling for 5 seconds. 
The cells were then incubated for 30 seconds in 100-fold excess of 
unlabelled L-methionine, The cell lysate obtained was treated as 
described above.
Precursor-product relationship
PCV-infected cell extracts were prepared at 30 minute intervals 
over a period of 5 hours as described in Chapter 2. The extracts were 
each divided into two equal parts; one part was analysed by 
electrophoresis on low percentage (8^) polyacrylamide gels followed 
by autoradiography in order to detect any large molecular weight capsid 
protein precursors. The other was analysed on high percentage (l2?o) 
polyacrylamide gels to detect low molecular weight virus-induced 
polypeptides, especially the minor polypeptide of molecular weight 
15,000 first described by Burroughs and Bro\-m (1974), the presence of 
which in calicivirus particles is still a subject of controversy 
(Schaffer & Soergel, I976)*
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RESULTS
Protein synthesis in FCV-infected cells
In several picornavirus-ce11 systems, host cell protein 
synthesis is severely inhibited in infected cells shortly after 
infection to such an extent that only virus-specific proteins are 
found later in the viral growth cycle. These can be analysed directly 
by polyacrylamide gel electrophoresis after a radioactive amino acid 
is added to the infected cells at the appropriate time.
Fig. 4*2 shows the rate of protein synthesis in PCV-infected 
and uninfected cells. The rate of cellular protein synthesis in the 
uninfected cells kept as controls remained constant over a period 
of 4 hours during which samples were taken for analysis.
By contrast, there was a dramatic fall in cellular protein 
synthesis within 0^ minutes and up to $0 minutes after infection 
with PCV. This was followed by a sudden upsurge of protein synthesis, 
presumably virus-specified, which continued till the end of infection. 
Evidence suggesting that the newly synthesized protein was virus- 
specific was obtained from two sources. First, viral infectivity of 
cell lysates was monitored by plaque assay and it showed an initial 
decrease, followed by a gradual increase concomitant with the build­
up of viral proteins in infected cells (Pig. 4*2). Figure 4*3 also 
shows the rate of protein synthesis in infected cells expressed as a 
proportion of the rate in uninfected cultures. Secondly, polypeptide 
analysis by gel electrophoresis and autoradiography revealed that the 
virus-induced polypeptide (p65) was not detectable in infected cells 
until about 2J--34 hours after infection and increased in amount 
thereafter (Pigs. 4 .4 and 4.3).
The significance of this result was that it showed the period 
during the life cycle of the virus when protein synthesis in the 
cell was minimized in favour of virus protein synthesis which was 
greatly increased. Analysis of virus-specific protein in subsequent 
studies was performed during the period when most of the protein 
being produced was virus-specific.
Subunit components involved in PCV assembly
Among the major viral proteins found in the cytoplasm of 
picornavirus-infected cells, for example, poliovirus, the large 
polypeptide NGVP^ is unique in that it is highly labelled only if 
cells are harvested within about I5 minutes after addition of the 
radioactive amino acids. If the cells are harvested after 30 minutes
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Figure 4*2 The rate of protein synthesis in FCV-infected cells
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Figure 4o3 Rate of protein synthesis in FCV-infected cells 
expressed as a percentage of uninfected controls
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Figure 4,4 legend
FEA cells were infected with FCV. At 30 minute intervals 
throughout the virus growth cycle the cells were labelled with 
^H-leucine for a 15 minute period. Cell lysates were prepared 
and analysed by polyacrylamide gel electrophoresis on lOÇ^  gels. 
This figure shows the resulting gel stained with Coomassie 
blue.
Tracks A-K represent the total protein content (pre­
existing and newly synthesised) of the cells during each 
30 minute period.
A Uninfected cell
B 0 - 30 minutes
C 50 - 60 »'
D 60 - 90 "
E 90 - 120 '»
F 120 - 150 "
G 150 - 180 "
H 180 - 210 •*
I 210 - 240 "
J 240 - 270 "
K 270 - 300 «
Numbers 1-5 represent the relative migration of standard 
proteins used as markers
1 Jl- galactosidase ( 130,000)
2 phosphorylase a ( 94,000)
3 catalase ( 60,000)
4 alooholdehydrogenase ( 41,000)
5 carbonic anhydrase ( 29,000)
The small arrow on the right indicates the position of 
the newly synthesised FCV capsid protein which in this analysis 
had an apparent molecular weight of about 68,000 daltons but 
was termed p65 for convenience. The p65 appeared first between 
180 and 210 minutes post-infection.
Figure 4.4 Analysis of FCV-infocted cell extract for protein
by polyacrylanide gel electrophoresis
Figure 4.5 legend
This shows an autoradiograph of the same gel as in 
Fig. 4 .4.
Tracks A-K represent the protein synthesised during 
each period of radiolabelling.
A Uninfected cell
B 0 - 30 minutes
C 30 - 60 "
B 60 - 90 "
E 90 - 120 '*
F 120 - 150 "
Or 150 - 180 ’*
H 180 - 210 »»
I 210 - 240 »
J 240 - 270 "
K 270 - 500 »
Numbers 1-5 represent the position of the marker 
proteins as in Figure 4*4*
The middle arrow on the right shows the position of 
FCV capsid protein (p&5) which first appeared in infected 
cells at 150 minutes post-infection.
Top and bottom arrows indicate the presence of infected 
cells of two additional protein bands of molecular weight 
80,000 and 40,000. Both protein bands appeared at 210 minutes 
post-infection and persisted until the end of the growth 
cycle at 5 hours.
Figure 4.5 Analysis of FCV-infected cell extract for newly 
synthesised protein by -polyacrylamide gel 
electrophoresis
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or after a pulse followed by a long chase, very little labelled NCVPi 
is seen in infected cell extracts. The disappearance of NCVP^, however, 
is mirrored by an accumulation of counts in the region of the gel 
where the procapsid proteins (VPq , VP^ and VPj) are found, suggesting 
that the polyprotein has been converted to specific procapsid proteins.
Using this pulse-ohase method, attempts were made to find a 
polyprotein analogous to the poliovirus NCVP^ FCV-infected cell
extracts. Four experiments were carried out.
Experiment 1 FCV-infected cells were pulse labelled for 5 minutes 
and then chased for 0, 5, 15» 30 and 60 minutes and the cell lysates 
were analysed on linear sucrose gradients by rate zonal ultra­
centrifugation using ^4c_i0ucine 5S and 153 FCV subunits as markers.
The result (Fig. 4«&) showed that both 153 and 58 subunit 
structures were present in FCV-infected cell extracts, thus confirming 
the belief that these subunit components might be intermediates in 
the assembly pathway of the virus.
Other interesting results observed included:
1) The preponderance and the non-disappearance of the 153 subunit 
in infected cells.
2) The probable existence of two or three other intermediates
between the 53 and 158 subunit components.
3) The appearance of whole FCV particles in infected cells 
about 30 minutes after the initiation of viral protein synthesis 
(Fig. 4 .60).
Experiment 2 In this experiment, the pulse time of infected cells was 
shortened to 1 minute and no chase was carried out. Analysis of the 
harvested cell extracts (Fig. 4*7) showed that even within one minute 
of the initiation of viral protein synthesis, both the 153 and the 
53 subunit components were already present in infected cells. Also 
the radioactive peaks between the 53 and the I5S components found in 
the previous experiment became more prominent. In addition, a new 
peak suspected to contain viral polypeptide (p65) was seen at the top 
of the gradient. Evidence confirming this view was obtained by 
centrifuging a purified p65 sample obtained by guanidine hydrochloride 
agarose chromatography with 53 and 153 vims subunit markers under
similar conditions and it was found that the p65 did not migrate but
remained at the top of the gradient (Fig, 4*3)*
This result showed that FCV polypeptide could be demonstrated 
in infected cell extracts but it still remained unclear whether it
55
Viral subunits in FCV-infected cells -1
1
V
16 24
FRACTION N O — >
32
12
10
8
6
4
2
0 3316 248
FRACTION NO -
a.
U 24
FRACTION N O ---
32
9.
1
u
3316 24
FRACTION N O — »
Infected cells were pulsed for 5 minutes (a) and chased for 15 minute: 
(b), 50 minutes (c) and 60 minutes (b)o
Dotted lines represent I5S and 5S ^'^0-labelled FCV subunit used as 
markers «
Fiis^ gre 4,7 Viral subunits in FCV-infected cells - 2
20
Fraction no
-# e # • labelled viral proteins
^4(j„Xabelied 15S and 58 FCV subunit markers
Fifflire 4.8 Sedimentation behaviour of FCV major polypeptides 
in sucrose gradients
fraction NO r—
15s and FCV sudunit markers _o- 
14c-.FCV polypeptide (p65)
-O-
was a primary gene product or a breakdown component of the 15S 
virus subunit.
Experiment 3 In this experiment, the shortest possible pulse of 
racLiolabel was used, in an attempt to find if there was a precursor 
of the 15s component, PCV-infected cells, 200 minutes post-infection, 
were labelled for a period of 5 seconds and then chased for $0 
seconds, 5» 15 oi" $0 minutes as described above and the extracts 
were analysed as before. The results of this study are shown in
Pig. 4,9,
When pulse-labelled for 5 seconds with no chase (Fig. 4*9a) 
the most abundant viral component was the polypeptide (p65) which 
formed 26^ of the total of newly synthesized viral proteins. Within 
this short period, other viral structures sedimenting at 98 and 
lis were also observed in infected cell extracts. It was not clear 
whether these were direct primary gene products or were formed from 
the p65. However, a rapid depletion in the amount of p65 was reflected 
in a corresponding increase in the amount of 58 subunit component; 
and at the same time two other viral structures sedimenting at IJS 
and 15s appeared in infected cells, $0 seconds after the initiation 
of protein synthesis (Fig, 4•9b) Shortly after synthesis, the 98 
component disappeared completely while the p65, 58 and IIS structures 
continued to decrease in amounts in favour of the I5S component 
which later became the most labelled viral structure in infected 
cells (Figs, 4*9c>d), After about 50 minutes from the initiation of 
viral protein synthesis, whole PCV particles appeared in infected 
cells (Fig, 4.9e).
The movement of radioactivity in infected cells was also 
considered by comparing the total radioactivity in each peak at each 
time point. The results, in Table 4*1 and Fig. 4»10, showed a 
continued migration of radioactivity from the p65 and into the 
various intermediates before culminating in the 158 peak. The 
involvement of the 58, 98, 118 and 158 subunits in this process not 
only showed that the I58 component was generated from smaller subunit 
particles but also implicated the 98, 118 and I58 structures along 
with the 58 and I5S already clarified as possible intermediates in 
the assembly pathway of PCV particles.
In this study, that is, after 50 minutes of protein synthesis 
(Table 4*l), the ratio of the I7OS FCV particle to the 158 subunit 
component was 1:6, But in the I6 hour harvest, these structures were
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Figure 4».9 Virus subunits in FCV-infected cells - 3
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Infected cells were pulsed for 5 seconds (A) and chased for $0 seconds 
(b ) 5 minutes (C); 15 minutes (^ ) 50 minutes (E),
Dotted lines represent 158 and 58 subunit components used as markers.
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Conditions were as in Figure 4*9 A-D, but ^^0-leucine labelled I7OS 
whole virusJ I5S and 98 subunits were used as markers.
Table 4.1
Flow of 3îi-" protein in FCV-infected cells
Chase
Period
Proportion
170s 19s '
of total
19s
^H-nrotein in
us' 98
each ce: 
5S
raponent
p69
0 seconds 0 0 0 23'8 19-9 18*0 26.4
90 seconds 0 7*2 14*9 17-9 17-6 24*0 12‘ 0
9 minutes 0 28*4 17-9 19"6 0 16' 9 10.9
19 minutes 0 32'9 20'9 19'o 0 12*7 8*2
50 minutes 6» 9 98-9 12«9 9-9 0 10.2 9*6
Figure 4.10 Flow of ^H-proteln in PCV-infected cells
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observed as peak I and peak II and the ratio increased to 1:10.
This increase could be explained by the disappearance of the smaller 
subunit particles into the I5S peak.
Experiment 4 Before the 9S, U S  and I3S structures could be regarded 
as possible intermediates in FCV assembly, it was necessary to show 
that they were virus- rather than cell-specified. Accordingly, FCV- 
infected cells were pulse labelled with 600^Ci of ^^S-methionine 
for 5 seconds and chased for $0 seconds (Pig. 4*H)* Cell extracts 
were prepared as before and samples of each radioactive peak (p65,
53, 118, 13s and 15S) were analysed by slab gel electrophoresis and 
aut orad iography.
The result (Fig. 4*12) showed that all of the putative 
intermediates contained the major virus-induced polypeptide, p65* 
Investigation of possible precursor-product relationship 
High molecular weight proteins FCV-infected cells were analysed for 
specific virus-induced polypeptides. This was achieved by labelling 
the cells with ^H-leucine at a time when most of the protein synthesis 
was virus-specific (Fig. 4*2), preparing cell lysates and selecting 
the virus-related polypeptides from these by precipitation with anti­
viral serum. The serum used was from a specific pathogen free cat 
infected intranasally with FCV Cl. It was anticipated that the cat 
would have been exposed to all of the antigenic determinants of proteins 
induced by the virus during its replication jjp ZÎX2.» so that the 
antiserum would precipitate not only capsid proteins but also any 
non-struetural virus-specified polypeptides which appeared in infected 
cells.
As sho\m in Figure 4*13, analysis of cell extracts for specific 
virus-induced polypeptides following immunoprécipitation with cat 
antiviral serum on low percentage (8 0^) polyacrylamide gels revealed 
no large capsid protein precursors in FCV-infected cells. Although 
traces of a virus-induced polypeptide of molecular weight 80,000 appeared 
transiently in infected cells between 2 ^ - 3  hours after infection 
(track F and G in Fig, 4*13), the major virus polypeptide (p65) still 
remained the only virus-induced polypeptide found in PCV-infected 
cells. This result was in partial agreement with the observations of 
Black and Brown (1977) who found 3 polypeptides with molecular weights 
100, 80 and 65x10  ^ in calicivirus-infected cells; but the result of 
the present study failed to support the presence of a polypeptide of 
molecular weight 100,000,
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Fifflzre 4oil Isolation of viral subunits prior to virion assembly
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At about 200 minutes,post-infection, the cells were pulsed with 55s. 
methionine for 5 seconds and chased for 30 seconds, The various 
intermediate subunit components were harvested on 15-30% sucrose 
gradient after centrifugation at 30,000rpm for 20 hours.
Figure /j.l2 Polyneptido analysis of PCV subunit cnnnonents
I5S 13S lis 5S p65
The various subunit components made prior to FCV assembly were 
analysed for viral capsid protein by PACE and autoradiography.
All subunit components had a capsid protein of molecular weight 
63,000, Feline leukaemia virus glycoprotein (gp?0) and protein (p27/ 
were used as markers in track F.
Fifflire 4*13 legend
PEA cells were infected with PCV. At $0 minute 
intervals throughout the virus growth cycle, the cells were 
labelled with ^H-leucine for a 15 minute period. Cell lysates 
were prepared and analysed by precipitation with cat antiviral 
serum followed by polyacrylamide gel electrophoresis and 
autoradiography. This figure represents the virus-induced 
polypeptides synthesised during each period of radiolabelling.
A Uninfected cell
B 0 - 50 minutes
C 30 - 60 "
D 60 - 90 "
E 90 “ 120 "
F 120 - 150 "
G 150 - 180 "
H 180 - 210 »
I 210 - 240 '»
J 240 - 270 ”
K 270 - 500 "
Numbers 1-4 represent the relative position of standard 
proteins used as markers.
1 phosphorylase a (94»000)
2 catalase (60,000)
5 alcoholdehydrogenase (41,000)
4 carbonic anhydrase (29,000)
Double arrows show the position of a high molecular 
weight protein (p80).
Single arrow shows the major capsid protein (p6b).
Figure 4«13 Immunoprécipitation and analysis of FCV-infected
cell extract on polyacrylamide gels
However, analysis of cell lysate for total (i.e. cellular and 
viral) newly synthesised proteins showed the presence of two polypeptides 
of molecular weights 80 and 40x10^ daltons (Fig. 4*5, tracks H-K), Both 
p80 and p40 first appeared in infected cells at about 3a' hours post- 
infection; that is, an hour after the detection of p65 in infected 
cells. Although these were highly labelled and did not decrease in 
amount after synthesis, their time of appearance in infected cells 
suggests that the synthesis of p80, p65 and p40 is independent.
Low molecular weight proteins Using the cat antiviral serum, a 
similar analysis of FCV-infected cell extracts on high percentage (l2^) 
polyacrylamide gels was carried out to confirm the presence of the 
minor polypeptide in infected cells. The result (Fig. 4*14) showed 
traces of a polypeptide of molecular weight of about 13-15,000 daltons 
appearing in infected cells between 3& and 4& hours post-infection and 
disappearing thereafter.
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Figure ^.14 Immunoprécipitation and analysis of FCV-infected ce]
extract on 12^ / polyacrylamide- gels
2-
Keys A-K and 1-4 are as in Pig. 4•15»
FCV-infected cell extracts were analysed on 12>o nolyacrylamiJe 
gels to detect the presence of any low molecular weight 
capsid protein.
Top arrow indicates p6p.
Bottom arrow shows the presence of a minor capsid protein of 
about 14,000 molecular weight.
DISCUSSION
The aim of the present study was to gain further understanding 
of the assembly process of feline calicivirions and to compare this 
process with that in picornaviral systems.
The contention that I5S and 58 subunit particles were precursors 
in the maturation of FCV was reinforced by the following findings:
a) Whole virus particles, under controlled conditions (see Chapter 5)» 
could be sequentially dissociated into I5S and 5S viral subunits,
b) Such intermediate (I5S and 5S) particles could be detected in FCV- 
infected cells synthesizing only virus-induced polypeptides
(Fig. 4.6).
c) The isolation of 118 and 158 components in infected cell extracts 
is not a unique feature of feline caliciviruses: a similar 158 
subunit has been found to play an important role in the,assembly 
of Eî'IC virus (Fig. 4«l6).
d) The kinetics of labelling of these intermediates and the subsequent 
assembly of the mature virion in infected cells is consistent with 
the role of these subunit structures as precursors (Fig. 4*10,
Table 4«l)»
e) The polypeptide composition of the 158 and 58 subunits, and indeed 
of the lis and 158 components, is very similar to the capsid protein 
(p65) found in the mature virus particles (Fig. 4*12).
Despite the similarities in their dissociation and assembly 
properties (Figs, 4*15, 4*18 & 4*17) the mode of replication in FCV is 
basically different from that observed in picornaviruses. For example, 
replication in picornaviruses has been shown to involve post- 
translational cleavage of precursor proteins (Summers & Ilaizel, I968; 
Holland & Kiehn, I968; Jacobson & Baltimore, I968) and in some instances, 
a polyprotein molecule thought to be the progenitor of capsid proteins 
has been demonstrated in picornavirus-infected cells (Jacobson & 
Baltimore, 1970; Holland & Kiehn, 1970).
By contrast, analysis of FCV-infected cell extracts by pulse- 
chase experiments failed to support the presence of any polyprotein 
precursor analogous to the NCVPj found in picornavirus-infected cells; 
instead, the most predominant viral structure found in infected cells 
was the I5S component, which, rather than being converted into other 
capsid protein, was itself constructed from smaller subunits and remained 
a permanent end product.
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The first attempt to demonstrate large molecular weight 
protein precursors yielded only the capsid protein of the virus and 
no larger precursor polypeptides could he detected (Black & Brown,
1975/76). In later studies two additional FCV-induoed polypeptides 
(plOO and p80) were reported in cell extracts although they here no 
precursor-product relationship to the p65 (Black & Brown, 1977&).
Analysis of FCV-infected cell lysates in the present study by 
immunoprécipitation and autoradiography (Fig, 4*13) showed that apart 
from p80 found in traces for a short period, the only virus-induced 
polypeptide was the capsid protein, p65. Although both p80 and p65 
appeared in infected cells at about I50 minutes post-infection, the 
p80 was present in submolar amounts and disappeared about 0^ minutes 
after the initiation of synthesis. The p65, however, prominently 
increased in amount and became the only capsid protein identifiable 
in FCV-infected cells. From these results, it is doubtful if the p65 
was a product of cleavage from the p80. Black & Brown (1977) however, 
suggested that the synthesis of p80 and p65 were independent of each other, 
One particular point of interest in this study is that neither pSO nor 
p40 were recognised by the cat antiviral serum when cell lysates were 
analysed by immunoprécipitation. This suggests that both p80 and p40 
might be enzymes required for the replication and assembly of PCV 
particles in infected cells. If this assumption is correct, then two 
separate polypeptides of molecular weight 80x10^ daltons can be 
identified in FCV-infected cells, the first appearing in infected cells 
at about 2j- hours post-infection and disappearing $0 minutes later 
(Fig. 4*13» tracks F and C) and the other appearing at about 5‘2 hours 
post-infection and persisting until the infection was stopped after 
5 hours (Fig. 4.5, tracks H-K).
The presence of a minor polypeptide of molecular weight 15,000 
in FCV particles was first described by Burroughs and Brown (1974).
Recent studies by Schaffer and Soergel (1976) failed to support the 
presence of this polypeptide in caliciviruses. In Chapter 5, 
chromatographic analysis of the polypeptide of 5S subunit component 
obtained by sequential virus dissociation revealed the presence of a 
minor polypeptide of molecular weight 15,500 in addition to the major 
capsid protein, p65. In the study described in this Chapter a minor 
polypeptide of molecular weight about 14,000 was observed when FCV- 
infected cell extract was analysed by immunoprécipitation followed by 
electrophoresis on 12^ polyacrylamide gels (Fig. 4 .I4 ), These results
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show that a minor polypeptide of about 13-14,000 molecular weight is 
indeed present in FCV-infected cells.
In cells infected with typical picornaviruses a virion-size 
single-stranded R M  (Levintow, 1974) appears from which a giant 
polypeptide is translated before progressing by cleavage to form capsid 
proteins (Fig, 4«l). The detection of two virus-induced polypeptides in 
FCV-infected cells with no evidence of precursors or post-translational 
cleavage raised the question as to whether the polypeptides were 
synthesized from the single 57S viral Rif A, as in picornaviruses, or from 
individual subgenomic mRlTA molecules synthesized after infection. To 
date, internal initiation of protein synthesis has not been demonstrated 
in eukaryotic cells so that it seems likely that subgenomic RNAs are 
involved in the replication of FCV,
Evidence in support of this was obtained from the work of 
Ehresmann & Schaffer (1976) who found that multiple classes of RITA 
were synthesized in cells infected with caliciviruses. The predominant 
single-stranded RITA of molecular weight 2*6x10^ sedimenting at 56S 
was genome size. There was also a prominent 22S single-stranded RITA 
component with a molecular weight of 1*1x10^ and one or more double 
stranded, or partially double stranded, components. Black and Brown 
(1975/76) suggested that the 228 subgenomic raRNA was translated into 
the major polypeptide (p65). Thus it appears that calicivirus 
replication involves the synthesis of subgenomic mRITA which is then 
translated to provide the coat protein and possibly the other virus- 
induced polypeptides found in infected cells.
This mode of replication is similar to that described 
previously for Semliki Forest virus, a group A togavirus, and tobacco 
mosaic virus (TMV), In Semliki Forest virus-infected cells, single 
stranded 428 R M  is the virus genome and 26S "interjacent" RITA serves 
as mRITA for virion polypeptide synthesis; double stranded replicative 
forms appear to be heterogenous (Levin & Friedman, 1971; Pfefferkorn 
& Shapiro, 1974; Wengler & Wengler, 1976), In H'-TV-infected cells, the 
major virus-specified polypeptide synthesized is the coat protein 
(Jockusch, 1968; Gianinazzi, Vallee & liartin, I969; Van Loon & Van 
Karamen, 1970; Poke, 1972). Two other large polypeptides were 
translated ^  vitro from the virus R M  whereas coat protein was 
translated from a separate subgenomic raRNA (Bruening et al, 1976; 
Higgins, Goodwin & Whitefield, 1976),
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Caliciviruses were considered as provisional members of the 
family picornaviridae (Melnick e_t 1974î Fenner, 1976) at a 
period of incomplete knowledge of their molecular biology. Evidence 
is now accumulating to suggest that the caliciviruses belong to a 
new and separate family of viruses and as such should not be 
classified as picornaviruses. The major difference in the strategy 
of replication of the caliciviruses and picornaviruses described 
above provides an addition to an already long list of differences.
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CHAPTER 5
AITTIGElfS OF FELIHE CALICIVIRUS
43
imODïïCTION
Although extensive studies have "been made on the serological 
relationships among feline caliciviruses (Povey, 1974» Povey & 
Ingersoll, 1975) the nature and number of antigenic determinants 
on the virus particles still remained undefined.
In Chapters 5 and 4, a naturally produced 153 subunit component 
encountered during virus harvest was described. This component, as 
well as the 17OS virus particle contained the single major capsid 
protein of molecular weight 65,000, Furthermore, the amount of capsid 
protein in the subunit peak was found to be 10 times more than the 
virus peak. Subsequent studies by controlled virus dissociation and 
in vivo virus biosynthesis showed that the 153 subunit was an 
intermediate structure in the pathway of virion assembly.
The aim of the present study was to determine and compare the 
antigenic properties of the 153 subunit with the whole virus particles. 
This was done by raising antisera to FCV and 153 subunit antigens in 
rabbits and reacting the antisera with the homologous and heterologous 
antigens in immunodiffusion tests. Both antisera were also subjected 
to virus neutralization tests by the plaque reduction method.
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MTERIALS AND IIETHOBS
Preparation of antigens
PCV and 15s virus subunit components were purified from 600ml 
of infected cell culture fluid as described in Chapter 3* Each 
purified component was made up to 5nil with TS and then pelleted by 
centrifuging in an SW 50.I rotor at 45,OOOrpm for 6 hours. The pellet 
was resuspended in 1ml of TS and then divided into two 0*5ml amounts: 
one aliquot was used for immunisation of rabbits and the other was 
stored in liquid nitrogen and was used later as a booster inoculum. 
Preparation of sera
Two rabbits, one for each antigen, were used. Prior to 
inoculation, the rabbits were bled and the sera were screened for 
anti-FCV antibodies by a neutralization test. The sera contained no 
virus neutralising antibodies.
For immunisation, 0'5ml of antigen was mixed with an equal 
volume of Freund's complete adjuvant (Miles Laboratories) and the 
mixture was vigorously shaken until an emulsion had been formed.
That the emulsions formed were satisfactory was shown by the non­
dispersal of the emulsions when dropped on a water surface.
The antigens were then administered by intramuscular injections 
into each hindleg. Four weeks later, the remaining antigen stored in 
liquid nitrogen was similarly inoculated. Seven days after the second 
inoculation, the rabbits were again bled to harvest immune sera.
Both pre-immune and immune sera were then subjected to neutralisation 
tests by the plaque reduction method.
Immunodiffusion tests
An adaptation of the double diffusion method of Ouchterlony 
(1948) was used. Two ml of molten 1^ agarose (Miles Laboratories) in 
PBS at 44°C was carefully poured on to a clean microscope slide and 
allowed to solidify at room temperature, A basic hexagonal 
arrangement of six evenly spaced wells, 6mm apart, with a central well, 
was made in the gel. Samples of about 10^1 of antigen or antisera 
were carefully dropped into the appropriate wells using a micro­
pipette. The slides were incubated in humidified chambers at 4°C 
for 3-4 days and washed in PBS for another 2 days. Where staining was 
required, the gels were dried in an oven (36°C) overnight and stained 
with 0*11^ 0 amide black for 3O-6O minutes before destaining in 7*5?^  
acetic acid - 5?^  methanol. Precipitin lines were examined visually 
and where necessary with the aid of a hand lens.
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Serum absorption
A volume of 25yt/l of rabbit antiviral serum was absorbed 
with 10(^1 of concentrated purified I5S virus subunit at 4^C for 
1 hour. Both absorbed and unabsorbed sera were reacted with the 
virus antigen by immunodiffusion. The remainder of the absorbed 
serum along with the unabsorbed and anti-158 sera were used in 
neutralization tests. Similarly, both dissociated and natural 158 
subunits were absorbed with excess 15S antiserum and then reacted 
with the unabsorbed antiserum by immunodiffusion.
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RESULTS
Immune sera
Analysis of rabbit antiviral and anti-15S sera by virus 
neutralization showed that both had a titre of 40 (Table 5«l) 
indicating that the antigens used had a common determinant which 
evoked neutralizing antibody or alternatively, that 2 or more separate 
antigenic determinants were involved in neutralization.
Immunodiffusion tests
The antigenicity of whole PCV particles and the 15S subunit 
component was examined by immunodiffusion and the results are 
represented in Pigs. 5.1 - 5.5. The reaction of anti-FCV and anti-15S 
antisera against the virus antigen (Fig, 5.I) showed that both 
antisera were reactive against FCV antigen. Only one determinant was 
observed on the I5S subunit compared to two on the whole virus 
particles; one of these showed a reaction of identity with the I5S 
determinant.
As expected, both anti-viral and anti-153 antisera showed a 
reaction of identity against a I5S antigen (Fig, 5.2), This common 
determinant was probably responsible for producing neutralizing 
antibodies in FCV and the I5S immune sera (Table 5.l).
Absorption of■serum by the shared antigenic determinant
Immunodiffusion The absorption of the common antibody from 
antiviral serum with excess 15S antigen was performed to isolate the 
virus-specific antibody and to test whether it had virus 
neutralizing activity. The result of the reaction between absorbed and 
unabsorbed sera against virus antigen in immunodiffusion is shown 
in Fig, 5.5. This experiment further confirmed that the unabsorbed 
antibody was virus-specific,
Neutralization When subjected to virus neutralization assay, along 
with anti-FCV and anti-153 antisera, it was found that the virus- 
specific antibody had no neutralizing capability (Table 5.2).
It would appear, therefore, that the neutralizing activities 
of the viral and I5S antisera were specific functions of the shared 
antibody (Table 5.I).
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Table 5.1
The neutralizing activity of anti-FCV I7OS and anti-153 antisera
Serum dilution
Pre - immunj. sation
1:5
1:10
Cat
anti-virus
serum
44
55
Rabbit
anti-virus
serum
Rabbit 
anti-15s 
serum
Number of plaques per plate 
at each serum dilution
45
51
45
49
Post-immunisation
1:5
1:10
1:20
1:40
1:80
1:160
1:520
1:640
0
0
2
5
25
54
40
51
0
0
0
5
21
29
36
49
0
0
2
9
27
55
44
Control assay (no serum) - 56 plaques/plate
Fi pire 3.1 Immunodiffusion of anti-?C7 and anti-133 
antiscra against virus antigen.
\
A V S  1
VA = virus antigen 
AVS = antiviral scrun 
AFS = anti-153 serun
Figure 3*2 Immunodiffusion of anti-FCV and anti-133 antiscra
against 153 antigen
O av s
o
FA
O a f s
AVS = antiviral serum 
FA - 13s antigen
AFS = anti-15S serum
F i gi-ire 3 « 3 Absorption of serum by the shared anti~enic determinant
FAB
VA = virus antigen 
k’'J3 = antibiral serum 
FAB = FCV absorbed serun
FCV antiserum was absorbed in excess I5S antigen
Table 3.2
Virus neutralization test of FCV absorbed serum
Serum dilution Anti-FCV serum Anti-FCV serum Anti-13s
(Unabsorbed) (absorbed)
Number of plaques per plate
1:5 0 45 0
1:10 0 ^ 49 0
1:20 0 48 1
1:40 4 51 7
1:80 27 54 29
1:160 55 52 57
Titre of serum: 40 5 40
Control assay (no serum) = 35 plaques
Comparison of the antigens of "natural" and "viral" 153 subunits
It was also observed that the naturally occurring I5S component 
(peak 11) was antigenically identical to a corresponding component 
obtained by particle dissociation (Pig. 5«4)« When each structure 
was absorbed with excess anti-133 antiserum, the absorbed serum 
failed to react against its homologous antigen (Pig. 3.5).
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Figure 5.4 Inmunodiffusion of viral 153 and peak II antigen;
against anti-153 antiserun
Oo
O
AFS
AFS = anti-153 serum
N = naturally produced I5S (peak II)
D = dissociated 153 antigen
Figure 5»5 Absorption of serum by dissociated and natural 
15s subunit antigens
O d  O n
Immunodiffusion in agarose gel.
AFS 1= anti-153 serum 
N = natural I5S antigen
D = dissociated 153 antigen
DA = dissociated 153 antigen absorbed with anti-153 serum
IÎA *= natural I5S antigen absorbed with anti-153 serum
DISCUSSION
Immunodiffusion tests were preformed to determine and compare 
the antigenicity of PCV particles and of the 153 subunit component. 
The results of this study revealed that 2 antigenic determinants 
were present on the surface of PCV particles (Pig. 5*l)« The fact 
that only one was found on the 153 component was suggestive that the 
virus-specific determinant was formed by the characteristic 
arrangement of the subunit components to form capsids during virion 
assembly. The ability to demonstrate the virus-specific antibody by 
removing the common antibody from antivirus antiserum by a serum 
absorption test (Pig. 5*5) was confirmatory evidence that two 
determinants did exist on the surface of PCV particles. Since the 
virus-specific antibody was shown to lack neutralizing antibodies 
(Table 5*2) it was, therefore, relatively safe to assume that the 
neutralizing activities of the viral and 153 antisera were specific 
functions of their common determinants.
In a parallel electronmicroscopic study to this, Ormerod 
(1973) found that 5 hours after infection in PEA cells with the FCV 
G1 strain, newly assembled viral particles were found in large 
intracytoplasmic aggregates or crystals. The cells were examined by 
immunofluorescence using the rabbit sera described here and PITC- 
conjugated anti-rabbit globulin. On reaction with the anti-PCV 
serum, fluorescence was observed diffusely throughout the cytoplasm 
and also brightly in several cytoplasmic foci. These latter were 
assumed to represent the crystals of viral particles seen by 
electronmicroscopy. Using the anti-153 antiserum, only the diffuse 
fluorescence was observed. When the anti-FCV serum absorbed with 153 
subunit, as was described in the present study, was used, the 
fluorescence was focal. The conclusion from these results was that 
the 15s subunit appears in the cytoplasm and when it is assembled 
into mature viral particle an antigen (the common antigen) is 
concentrated into the aggregates of particles. When the antibody 
to this antigen was absorbed from the antivirus serum, the antibody 
to the unique, virus-specific antigen remained. These results confirm 
the present findings.
It may be that the multiple antigenic determinants on the 
FCV particle which were revealed in the present study are relevant 
to the antigenic variety which is observed among PCV isolates 
(Povey, 1974). In spite of these antigenic differences the existence
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of separate serotypes of FGV has not been established. Indeed there
is considerable evidence for common antigenic determinants both from
the results of neutralization (Povey, 1974) and cross-protection 
tests (Povey & Ingersoll, 1975)* It will be important now to examine 
further strains of PGV by the methods reported here to find whether 
there is an antigenic determinant which is common to all FGV isolates 
(group-specific antigen); and whether this is the antigen shared 
between the FGV particle and the 1$8 subunit.
In foot-and-mouth disease virus (FI®V) where similar antigenic
sites have been described (Rowlands et 1971) both sites have 
been shown to produce neutralizing antibodies although the mechanisms 
by which the two antibodies function appear to be different. One site 
is concerned with the production of an antibody which neutralizes 
virus by preventing its attachment to cells while the other is 
concerned with the prevention of uncoating of the virus RNA. In this 
respect, the antigenic determinants of FGV particles differ from 
those of FI-IDV in that only one determinant (the common determinant) 
produce virus neutralizing antibody. The function of the virus- 
specific determinant still remains undefined.
Another interesting aspect of this study was that the whole 
virus and the 15S subunit component both possessed common antigenic 
determinants for the production of neutralizing antibodies in the 
respective immune sera. The immediate implication of this result 
was that the 15S antigen might possibly be useful as vaccine against 
feline calicivirus disease in cats. A prototype vaccine based on 
this idea was prepared and tested in this study and is discussed in 
the next chapter.
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CHAPTER 6
A FELINE CALICIVIRUS SUBUNIT VACCINE
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INTRODUCTION
Since the original isolation of the virus by Pastier (1957) one 
factor of particular interest about feline caliciviruses has been the 
antigenic variation which exists between various strains. Preliminary 
attempts to classify the viruses serologically suggested that numerous 
distinct serotypes existed (Bittle et I96O; Burki, I969; Crandell, 
1967). Subsequent cross-neutralization studies of 46 isolates, however, 
led Povey (1974) to suggest that there were in fact considerable 
antigenic relationships in the group and that the various isolates 
might be regarded as members of a single serotype* This study was later 
extended to in vivo situations for a total of 8 isolates by Povey and 
Ingersoll (1975) who postulated that such relationships might be 
reflected in cross-protection in cats infected with PCV*
A similar development occurred in attitudes towards vaccination 
against virus-induced respiratory disease in cats. Thus, at first it 
was considered that the antigenic diversity of PCV isolates, together 
with the poor immunogenicity of FHV, precluded the manufacture of an 
effective vaccine against these viruses. However, when the extent of 
cross-protection following infection with PCV became apparent, serious 
attempts were made to produce vaccines.
Due to the practical limitations of using all known antigenic 
strains in preparing a PCV vaccine, the F-9 strain, already known to 
be broadly antigenic and of low virulence (Kalunda _et 1975)» was used 
in several vaccine preparations either singly (Bittle & Rubio, 1976) 
or in combination with FHV and panleukopaenia virus vaccine (Bittle & 
Rubic, 1975; Davis & Beckenbauer, 1976). Kahn (1975)» in a series of 
studies, showed that there was a distinctly better protection using a 
single intranasal dose of F-9 strain than using two intramuscular 
doses of the same immunizing antigen. The apparent immunologic advantages 
of intranasal vaccination for both FHV and PCV infections prompted 
development of a bivalent, single does, modified live virus vaccine, 
marketed commercially as "Felomune" (Norden). Other commercially 
available FHV-PCV combined vaccines now include "Feliflu" (C-Vet) and 
Katavac CH (Duphar) administered intramuscularly and intranasally 
respectively.
Live vaccines are commercially attractive owing to the 
comparatively small quantity of antigen which may be used. There are, 
of course, several potential problems associated with their use, 
including the possibility of persistence in, and excretion of virus by
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the animal and the presence of extraneous infectious agents in the 
non-inactivated material* In fact, following the use of some live 
PCV-PHV vaccines in the field there have been indications that certain 
vaccinal viruses might not be completely attenuated (O. Jarrett - 
personal communication)*
Such considerations prompted Povey and Wilson (1978) to compare 
inactivated FHV- FGV vaccines with live modified vaccines* They found 
that a killed vaccine given intramuscularly with adjuvant in tv/o doses 
was marginally superior to the single dose of live modified vaccine 
described above*
Even killed vaccines have attendant side effects in that the 
chemicals used to inactivate the infectious RNA might cause unwanted 
reactions in animals or sometimes alter the protein responsible for 
activating the immune responses in such a way that protection is 
lessened.
There is an increasing conviction that vaccines could be made 
from the non-infectious components of viruses which are antigenically 
identical to the whole virus* In this way, the risks associated with 
the killed or attenuated virus vaccines can be averted. For example, 
of the three major proteins associated with the rabies virus envelope, 
only the glycoprotein was found on the external surface of the envelope 
and it has recently been shown to be responsible for inducing 
neutralizing antibodies in infected hosts (Dietzschold ejt 1978)#
When purified and used as vaccine, the glycoprotein vaccine had 
similar or better protective activity than a vaccine made from 
inactivated virus (Cox _et 1977). Similarly, a vaccine made from 
purified non-infectious glycoprotein (haemagglutinin and neuraminidase) 
components of influenza virus has been found to be equally protective 
and safer than killed or live modified virus vaccines (Kilbourne, 1975)»
In Chapter 3» the occurrence of a 15S subunit component 
encountered during the purification of FGV was described. This component 
was found to contain 10 times more protein than the virus peak in 
GSCI2 gradients, and the work in Chapter 4 indicated that this I5S 
component was a major intermediate product during virion assembly. A 
further confirmation of this was that the same antigenic determinant 
was present on the subunit and the whole virus. In addition, both 
homologous antisera exhibited virus neutralizing activities as 
described in Chapter 5*
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These findings suggested the use of the subunit as a vaccine. 
The present chapter concerns experiments in which cats were immunized 
with the purified non-infectious I5S subunit and were subsequently- 
challenged with virulent FGV,
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MATERIALS AND METHODS
Animals
Cats were obtained from the breeding colony of the University 
of Glasgow Department of Veterinary Pathology. Six one-year old 
cats were used.
Collection of samples for virus isolation
Live animals Oropharyngeal swabs of the cats were taken with the 
aid of a sterile cottonwool swab. The swab was broken into a glass 
bottle containing 2ml of EEC2 (MEM with 2^/o foetal bovine serum) which 
was then sealed. In the laboratory the cottonwool was removed from 
the bottle, the medium was centrifuged at 2000rpra for 10 minutes and 
the top I'Oml of fluid was removed and stored at -70°C prior to 
virus isolation.
At necropsy Samples of tissue were taken with sterile scissors into 
bottles and chopped into small pieces, Tw^ o ml of MEM were added and 
the suspension was agitated in a Whirlimix. The tissue suspension 
was centrifuged at 3,000rpm for 5 minutes and the supernatant was 
stored at -?0°C for virus isolation.
Virus isolation
Samples of lOOyui from each specimen were inoculated into each 
of two confluent PEA cell cultures and adsorption was allowed for 
1 hour followed by inoculation with 2ml of EPC]_o* The plates were 
incubated at 57°C and were examined daily until a CPE was observed, 
or 4 days had elapsed. At the end of 4 days, plates not showing CPE 
were regarded as negative.
Bacteriology
Oropharyngeal swabs from all experimental cats obtained 
before and after virus challenge were tested for the presence of 
bordetellae,p-haemolytio streptococci, haemophilia bacteria and 
pasteurellae. The swabs were each used to inoculate a 5/^  sheep blood 
agar plate, a 5% horse blood agar plate, a chocolate agar plate and 
a MacConkey agar plate. The sheep blood and MacConkey plates were 
incubated at 57°C aerobically, the horse blood plate anaerobically 
and the chocolate agar in an atmosphere enriched with CO2 for up to 
five days if growth was not observed to occur before then. Gram- 
stained films were made from representative colonies resembling those 
produced by the bacteria and cultures were examined according to the
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scheme given in '’Manual for the Identification of Medical Bacteria” 
by Cowan and Steel,
Analysis of postmortem tissues A portion of lung from each cat was 
submitted for bacteriological examination in the course of which 
material was removed with routine sterile precautions from a 
bronchiole with a glass pipette and examined in the same way as the 
swabs,
Histopathology
Small pieces of lung tissue were taken and analysed by 
histopathology for microscopic lesions by Dr I.A.P. McCandlish.
Intact lung lobes were fixed by instillation of 10^ neutral buffered 
formol saline into the main bronchus followed by immersion of the 
lobes in an excess of fixative. After 48 hours, representative tissue 
blocks were selected, trimmed and transferred to fresh fixative for 
a further 24 hours. The tissue blocks were then processed for 
histological examination by dehydration through an alcohol-chloroform- 
xylene series followed by embedding in paraffin wax. Sections were 
cut at 4-^ni and stained with Mayer's haemalum and eosin.
Vaccination experiments
Cats Six cats were used in this study. Four of them (numbered 1,
2 ,3 and 4) were vaccinated while the others (5 and 6) were kept as 
controls.
Preparation of vaccine Six hundred ml of clarified culture fluid 
from PCV-infected cells was mixed with 20ml of a similar preparation 
labelled with ^H-leucine (marker virus). The mixture was precipitated 
with an equal volume of saturated ammonium sulphate and centrifuged 
at 7,000rpm for 5 minutes. The precipitate was resuspended in pml 
of TS buffer and then centrifuged on a pad of CsCl2 and sucrose 
gradients as described in Chapter 3. The peak of virus materials was 
harvested and recycled on CsCl2 gradients in the SW 50.1 rotor at 
40,000rpm for l6 hours. The virus and 15S subunit components obtained 
were separately pooled and recycled on CSCI2 gradients as before.
The 15s subunit component was then made up to 5ml with TS buffer and 
pelleted in the SW 50,1 rotor at 45»000rpm for 6 hours. The pellet 
was resuspended in 5m1 TS and sonicated. The vaccine was then 
filtered through a 25nm Millipore filter to remove any virus particles 
which might still be trapped in the preparation. Of the 630,000cpm in 
the sample filtered, only 490,000cpm (77*7?^ )were recovered in the 
filtrate.
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A sample of 50^1 of the filtered sample was mixed with an equal 
volume of TS buffer and inoculated into a plate of confluent PEA cells 
at 37°C for 1 hour. After adsorption, 3ml of EPCpQ medium was added and 
the plate was re-incubated for 4 days. The cells were examined each 
day for evidence of CPE but remained negative until the plate was
discarded at the end of the fourth day.
Immunisation procedure The immunisation procedure was the same as for 
antiserum production in rabbits described in Chapter 5» Prior to 
immunisation, the cats were bled and the sera were screened for specific
PCV antibodies by virus neutralization tests. The immunogen was prepared
by mixing 0'5ml of the subunit vaccine with an equal volume of 1:10 
dilution of Alhydrogel adjuvant (Miles Laboratories). An experiment was 
done to determine the dilution of the adjuvant to be used with the I5S 
antigen fox* immunisation. Two-fold dilutions of aluminium hydroxide 
(Alhydrogel; Miles Laboratories) prepared in distilled water and a 25yl 
sample of each was added to an equal volume of the 5h-labelled I5S 
antigen preparation. The mixture was allowed to stand for 10 minutes at 
4°C and was then centrifuged at 5>000rpm for 5 minutes. The precipitate 
was resuspended in 50^ *1 of TS buffer. Radioactivity was estimated using 
NE 260 scintillation fluid and the amount of radioactive material 
precipitated by each dilution was expressed as a percentage of the 
radioactivity contained in a 25pi sample of I5S antigen used as control. 
As shovm in Pig. 6,1, maximum precipitation of antigen was achieved 
using a 1:20 dilution of Alhydrogel.
The vaccine was administered subcutaneously in a single dose 
in the neck region. A similar dose was administered A weeks later. Ten 
days after the booster dose the cats were challenged with IXlO^pfu 
of live PCV contained in 0'5ml of EPC2. Using a pipette, virus inoculum
was instilled in equal amounts into the nostrils.
The vaccinate and control cats were kept separately in rooms 
with a floor area of lOm^, about 30 feet apart. Any change in physical 
condition and demeanour could easily be observed.
The cats were examined daily for any clinical manifestations of
PCV disease. Oropharyngeal swabs and rectal temperature of the cats 
were taken on day 0 and day 1 and every other day thereafter. Seven 
days after the virus challenge, two vaccinates (Cats 2 & 4) and one 
control (Cat 6) were sacrificed and the others were killed at I4 days 
following challenge.
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The following organs or tissues were taken for virus isolation: 
tongue, tonsil turbinates, trachea, lungs, kidney, liver, spleen, 
retropharyngeal and bronchial lymph nodes. Both oropharyngeal swabs 
and lung tissues were taken for bacteriology but only lung was 
taken for histopathology.
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Figure 6.1 Titration of Alhydrogel adjuvant
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RESULTS
Virus isolations
Pre-inoculâtion oropharyngeal swabs and similar swabs taken 
from all 6 cats immediately before challenge were negative for 
PGV. Table 6,1 shows the results of attempts to isolate virus from 
the oropharynx of both vaccinates and control cats examined every 
other day during the period of virus challenge.
All the cats began to excrete infectious virus within 
24 hours following inoculation. With the exception of one vaccinate 
(Cat 4) which excreted virus for 48 hours, subsequent oropharyngeal 
swabs taken from the others proved negative. By contrast, virus was 
recovered from swabs of the controls up to the time of necropsy. The 
pharynx was the most consistent source of virus in infected cats.
Other workers have considered that the tonsils might be the site for 
continued virus multiplication in carrier cats which had been sho\m 
to excrete virus from the pharyngeal region for long periods (Povey 
et al, 1975)*
Bacteriology
Swab samples taken for bacteriology failed to reveal the 
presence of any pasteurellae, bordatellae or -haemolytic streptococci 
each of which could influence the course of calicivirus infection in 
cats. Also, none of the plates inoculated with materials from the 
lung yielded any growth.
Serology
The results of neutralization tests on pre- and post-inoculation 
sera are shown in Table 6,2. Prior to virus challenge, antibody titres 
of about 40 were observed in the vaccinates while there was no change
in titre of the unvaccinated control. The antibody titre of the
control cat examined at necropsy on day 7 post-inoculation rose 
slightly to 10 while a dramatic increase in titre to 40 was observed
in the other control cat killed on day I4 . The titre of the
vaccinates rose only slightly to about 80,
Clinical manifestations of FGV disease
Clinical signs of calicivirus disease in both the vaccinates 
and controls were monitored and the results are represented in Table 
6 .5* The vaccinates remained clinically normal throughout the period 
of virus challenge whereas the controls exhibited characteristic symptoms 
of PCV infection including a biphasic temperature rise (Pig. 6.2),
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Table 6.1
FCV isolation from oropharyngeal swabs (post-infection)
Cat No 5 6 1 2 3
Days
3
5
7
9
11
13
14
- positive virus isolation 
*= negative
Cats 6, 1 and 2 were necropsied on day 7- 
Cats 5» 3 a-Tid 4 were necropsied on day 14.
Table 6,2 Neutralizing activity of pre- and post-virus 
challenge sera
Pre-challenge sera
Controls Vaccinates
Cat No 5 6 1 2 5 4
Serum
Dilution
1/5 46
Number of plaques per plate 
51 0 0 0 0
1/10 49 45 0 0 0 0
1/20 48 48 1 5 0 1
1/40 51 54 6 7 4 6
1/80 49 51 29 24 27 51
1/160 52 47 40 57 41 59
1/520 50 48 49 50 46 52
B Post-challenge sera
Controls Vaccinates
Cat no 5 6 1 2 5 4
Serum
Dilution Number of plaques per plate
1/5 0 2 0 0 0 0
1/10 0 9 0 0 0 0
1/20 5 12 0 2 0 1
1/40 7 28 5 5 6 5
1/80 22 59 12 14 11 16
1/160 59 47 29 51 50 35
1/320 55 51 50 49 47 51
Number of plaques in control well = 58
Cats 6, 1 and 2 were necropsied on Day 7 after virus challenge 
Cats 5, 3 und 4 were necropsied on Day 14
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a progressive loss of condition, depression and inappetance. The 
mucous membranes of the mouth at some stage appeared inflamed but 
ulcers did not develop.
Post mortem examination
Gross pathology All tissues and organs examined post mortem appeared 
normal except in one of the controls (Cat 6) autopsied on day 7 where 
the lungs appeared purulent.
Virus isolation Isolation of virus from post mortem tissues of 
vaccinates all proved negative (Table 6,4). In the unvaccinated 
cat (Cat 6), necropsied on day 7, virus was recovered from the tongue, 
tonsils and the lungs; whereas only the tonsilar tissues were still 
found to be harbouring infectious virus in the cat (Cat 5) necropsied 
on day 14. The increase in titre of virus neutralizing antibody in 
Cat 5 was probably responsible for the elimination of virus from 
possible areas of isolation, e,g, tongue or turbinates,
Histopathology The histopathological findings on the lung tissues 
of the cats is shown in Table 6,5* No abnormalities were detected in 
the lungs of Cat 2, one of the vaccinates, but the others (Cats 1, 5 
and 4) showed mild bronchiolitis and alveolitis accompanied by 
cellular infiltration.
In the unvaccinated controls, histopathological lesions were 
prominent in Cat 5 involving focal alveolitis accompanied by extensive 
accumulations of macrophages in alveolar spaces. The alveolar walls 
were thickened due to mononuclear and polymorphic infilteration. 
Bronchiolitis and denudations of bronchiolar epithelium with peri­
bronchial and perivascular lymphoid tissue were also prominent.
The cat necropsied on day 7 (Cat 6) with a low titre (lO) of 
neutralizing antibody, in addition to the above lesions, had foci of 
proliferative interstitial pneumonia with hypertrophy and hyper­
plasia of type II pneumocytes. Alveolitis was generalised and 
occasional bronchiolitis were found, especially in pneumonic areas.
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Table 6.5 Clinical manifestation of FCV disease
Controls Vaccinates
Days
Post virus 
Challenge
5 6 1 2 3 4
0 Bright All food eaten
101*0° 101*4° 101*6°
Bright All food 
102*0° 100*6°
eaten
101*5°
1 4 food eaten
105*7° 105*3° 102*1° 101*8° 101*2° 100*8°
5 § food taken 
Dull
103'0O 102*6° 101*5°
Bright All food 
101*9° 101*0°
taken
100*7°
5 § food eaten 
Reddish mucous membranes 
Dull Very dull 
102*6° 102*1° 101*7°
Bright All food 
101*5° 101*8°
taken
101*0°
7
-J- food eaten 
Reddish & patchy 
mucous membranes 
105*0° 105*2° 100*9°
Bright All food 
101*5° 101*1°
taken
101*5°
9 3 food 
eaten 
Still dull 
105*4°
Bright
100*9°
All food 
taken
101*2°
11 4 food
taken
105*1°
Bright
100*6°
All food
taken
101*5°
15 f food
taken
Appears bright 
102*4°
Bright 
100* 8°
All food
taken
101*2°
14 ^ food eaten 
102*2°
Bright
100*7°
All food
taken
101-4°
Cats 6, 1 and 2 necropsied on Day 7 
Cats 5» 5 and 4 necropsied on Day 14
Table 6.4
FCV isolation from post mortem tissues
Cat No 
P.M. Tissues 
Tongue
Tonsil
Retropharyn. L.N.
Turbinates
Trachea
Lung
Spleen
Kidney .
Bronchopharyn. 
Lymph node
Controls
PM? PM14
Vaccinates
PM7 PM14
+ = Positive virus isolation
- = No virus isolation
PM7 and PMI4 = Gats necropsied on Lay 7 and 14»
Table 6.5
FCV Subunit vaccine; Post mortem lesions in 
vaccinate and control cats
Cat
Number Lung pathology Severity
Controls
Alveolitis, with focal accumulation of 
macrophages and polymorphs in alveolar 
spaces. Severe bronchiolitis and epithelial 
denudation of the bronchioles
++
Proliferative interstitial pneumonia with 
thickening of alveolar walls by mononuclear 
cellular infiltration. Hypertrophy and 
hyperplasia of type II pneumocytes. Severe 
alveolitis and bronchiolitis. Prominent 
peribronchial and perivascular lymphocytic 
infilterations.
+++
Vaccinates
Occasional focus of alveolitis and 
bronchiolitis. Peribronchial and perivascular + 
lymphoid foci.
No abnormalities detected
Occasional focus of alveolitis and bronchiolitis +
Alveolitis and bronchiolitis
DISCUSSION
The result of the vaccination experiment was interesting and 
encouraging. The vaccinated cats remained clinically normal 
throughout the period of virus challenge (Table 6.5; there were no 
significant pathological changes in one oat and in the others 
lesions were confined to mild bronchiolitis and alveolitis. By contrast, 
the unvaccinated cats exhibited clinical and pathological signs of 
infection associated with infection by this strain of PCV (E. Ormerod - 
personal communication). These included a biphasic temperature rise, 
progressive loss of condition, depression and anorexia. At necropsy, 
one of the controls had severe alveolitis and bronchiolitis and the 
other, in addition to these lesions had focal pneumonia. It would 
appear from these results that the vaccine protected against the 
effects of PCV infection. However, few experimental animals were used 
and until the vaccine is tested on a larger scale it is inappropriate 
to discuss its efficacy and duration of protection.
The present results were obtained with a vaccine prepared from 
purified I5S subunit which was filtered through a membrane with a 
pore size of 25 nanometres to remove any small quantities of 
contaminating infectious virus (see Plate 5.2). The reason for using 
partially purified material was to ensure that the antigen was well- 
defined and any biological effect which resulted from its use as an 
immunogen could be directly ascribed to it. In this way the experiment 
showed also that the I5S subunit acted as an antigen to evoke 
neutralizing antibodies, confirming the results in Chapter 5* Further 
experiments on the vaccine might profitably be done using filtered, 
crude, PCV-infected cell culture fluid to demonstrate that the 
expensive and time-consuming process of purification by centrifugation 
is unnecessary. However, it is likely that ultrafiltration would 
still be required as a final step in production.
An interesting question raised by the experiment reported here 
is to what extent the inactivated FCV vaccine described by Povey and 
Wilson (1978) relied on its presumed content of I58 subunit for its 
efficacy, in view of the fact, described in Chapter 5» that of the 
virus-specific components in viral harvests, the subunit (peak II) 
contains ten times as much viral protein as is in whole virus. It 
may be that by a process of filtration of the harvests, rather than 
chemical treatment, a superior immunogen is obtained. Further
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experiments require to be carried out to answer these questions. 
Feline calicivirus, therefore, joins influenza and rabies 
as examples of viruses from which a non-infectious subunit may be 
generated which acts as a vaccine against virulent virus challenge. 
The calicivirus vaccine is important not only for the use to which 
it might be put in cats, but in the context of a possible model for 
the development of future vaccines for other small R M  viruses of 
animals and man.
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CHAPTER 7
GENERAL DISCUSSION
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GENERAL DISCUSSION
The aims of this study were, to a large extent, accomplished. 
Substantial experimental evidence was provided to propose a scheme by 
which the virion of feline calicivirus is assembled from smaller 
subunits. By a study of the antigenic determinants of the virus and its 
major subunit, a non-infectious subunit vaccine was successfully 
developed. In addition, several observations were made which suggest 
avenues for further investigation of the molecular biology of PCV 
infection.
The purification of PCV as a preliminary step in studying its 
subunit structure yielded two homogeneous populations of viral components 
differing in density, sedimentation values, and not surprisingly, in 
content. The infective I7OS component was identified as PCV while the 
slower sedimenting component with a density of l*26g,cra”  ^was sho\m to 
contain an aggregate of viral proteins sedimenting at 15S, Although slow 
sedimenting non-infective viral components have been associated with 
other small RNA-containing plant and animal viruses (Mayer _et 1957; 
Kaper, I96O; Rhim et ad, I96I; SchmicLt ^  ad, 1965; Halperen et I964; 
Fabiyi et al, 1964; Planterose & Ryan, I965; Graves ^  ad, I968; Breese, 
1968), it is rather surprising how a similar component of FCV, in spite 
of its high protein content, has escaped detection until the present 
study.
One of the major attributes of the 153 subunit particle is the 
ability of its homologous antiserum to neutralize FCV infection as 
effectively as the antiviral serum in neutralization tests. When applied 
to in vivo situations, it was found that none of the cats vaccinated 
with the 153 antigen developed the calicivirus disease, whereas, 
the cats used as controls exhibited clinical signs of disease and one 
was found to be pneumonic at post mortem. Apart from its potency, the 
15s prototype vaccine has the advantage of being cheaply produced and 
this could be a valuable asset in terms of commercial preparations.
The fact that viruses make use of subunit construction was first 
gleaned from the field of X-ray diffraction (Caspar, 1956; Caspar & Klug, 
1962) and visualization of these subunits only became possible when the 
electron microscope technique of negative staining was applied to virus 
particles (Brenner & Horne, 1959)* More recently it has been possible to 
study the subunit structure of F & MDV (Talbot & Brown, 1972) Mengo and 
EMC viruses (O'Callaghan, I4ak & Colter, 1970; Lund _et al, 1974) mouse-
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elberfeld (MH) virus (Bunker & Rueckert, 197l) and rhinovirus (McGregor 
& Rueckert, 1977) by controlled particle dissociation thus throwing some 
light on the mode of assembly of these viruses. Argueing on a similar* 
basis, this thesis presents evidence that PCV is assembled in at least
2 stages and the supporting evidence is two-fold.
First, purified virus can be degraded by low pH into homogenous 
populations of smaller non-infective particles sedimenting at 158 which 
on exposure to reducing agents breaks down further into a 53 subunit.
Each of these contains a polypeptide of molecular weight 65,000 daltons 
(chapter 3) The second line of evidence was obtained by pulse-chase 
experiments of FCV-infected cells in which newly synthesized polypeptide 
is extremely rapidly converted into a 53 subunit which possibly through 
several unstable intermediates (93, 118 & 138) is incorporated within 
30 seconds into a 158 component. Between 15 and 30 minutes after the 
initiation of polypeptide synthesis, complete and infectious feline
calicivirions are formed in infected cells.
It should be noted that all of the work described in this thesis 
was done with one strain of PCV, the extra-large plaque type, G-1 
(Ormerod & Jarrett, I978). It is considered extremely unlikely that 
all PCV strains are not assembled in the same way; however, it would 
be useful in future work to compare the construction of several 
different FCV isolates.
Unlike poliovirus (Phillips & Pennell, 1973) EMC virus (McGregor, 
Hall & Rueckert, 1975) or foot-and-mouth-disease virus (Breese, I968), 
the 753 procapsid is not an intermediate in the assembly process of PCV,
No such structure is found in this study either by particle dissociation 
or in pulse-chase experiments of infected cells. The assembly of PCV, 
therefore, is more akin to the oardioviruses (Rueckert, 1971; McGregor, 
Hall & Rueckert, 1975) in which the capsid precursor proteins (5-68) 
aggregate to form a pentameric 158 and later I4S subunits which then 
associate with the newly synthesized RNA to form a complete virion.
It will be helpful in future studies to estimate the molecular 
weight of the 5 and I5S subunit components to determine whether the 
15s particle is a pentaraer of the 58 component as in EMC virus (McGregor, 
Hall & Rueckert, 1975) MS virus (Bunker & Rueckert, 197l), or a trimer 
as in foot-and-mouth disease virus (Talbot & Brown, 1972), In this way 
it might be possible to deduce the number and the configurational 
arrangement of the subunit components in the mature virion.
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Another subject for further experiments is the fact, discovered 
in this work, that there are (at least) two antigenic determinants on 
the PCV particle, one of which is shared with the 153 subunit while 
the other is unique to the whole virion. The common antigen appeared 
to be involved in the induction of virus neutralizing antibodies in 
cats and rabbits. It will be important to determine the biological 
significance of the other, unique antigen; and also to investigate how 
the serological cross-reactivity between different strains of PCV is 
related to the present findings.
It is relevant at this stage to return to the classification 
of FCV which is still controversial. Although the International 
Committee for the Nomenclature of Viruses (V/ildy, 1971) classified the 
caliciviruses as members of the family picornaviridae, evidence is rapidly 
accumulating which suggests that caliciviruses belong to a new family 
of viruses. The reasons are as follows:
a) The morphology of caliciviruses is quite distinct, the particles 
having a fringe-like appearance and an easily recognisable pattern 
of staining (Zwillenberg & Burki, I966; Almeida et aJ, I968; 
Wawrzkiewicz et aj, I968). By contrast, the picornaviruses show little 
or no structural detail (Newman et 1973).
b) The diameter of 35“40Din is significantly greater than the values 
(24-30nm) obtained for other members.
o) Published sedimentation values for caliciviruses range from I6OS to 
207s (Wawrzkiewicz et ad, I968; Oglesby et 1971; Newman et al,
1973) and are greater than those for other picornaviruses (I4OS-I6OS, 
Newman et ad, 1973)*
d) Caliciviruses have lower (iS^ o) RITA content (Burroughs et ad, 1978) 
compared to about 30/° found in other members of the picornavizus 
family (Rueckert, 1971).
e) Only one capsid protein is found in caliciviruses (Burroughs & Brovm, 
1974; Schaffer & Soergel, 1976) compared to 4 found in other members,
f) Typical picornaviruses show only virion size single stranded RNA 
(Levintow, 1974) whereas subgenomic RNA (multiple classes of RNA) has 
been identified in calicivirus-infected cell extracts (Ehresraann & 
Schaffer, 1977).
Cooper (1974) suggested that the genome strategy should be used 
as a major criterion in assessing the degree of relatedness among 
viruses and, on this basis, challenged the validity of the suggestion
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that caliciviruses be removed from the family Picornaviridae. However, 
Black & Brown (1975/76) have since shovm that the caliciviruses exhibit 
a strategy of replication which is completely different from the 
raonooistronic polypeptide translation characteristic of other members of 
the picornaviridae. The present study has confirmed and extended these 
studies. No evidence was found of a large molecular weight precursor 
of the capsid polypeptide p65 in PCV-infected cells using a different, 
and more sensitive, method from that of Black & Brown (1975/76). 
Nevertheless, the present study did show that PCV, like some 
picornaviruses, is constructed in at least two stages from smaller 
protein subunits.
Although the caliciviruses are similar to the picornaviruses in 
certain aspects, these various significant differences appear to favour 
the suggestion (Burroughs & Brown, 1975» Newman et al, 1973; Ehresmann 
& Schaffer, 1977) that the caliciviruses be regarded as forming a new 
family, the Caliciviridae.
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